About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Transdermal estrogen
- Company
- Johns Hopkins University
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 110 recruiting
Efficacy results: Not yet reported
110 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026
Find a Clinical Trial Near Me
See recruiting studies for Transdermal estrogen and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02081924
Reproductive Hormones During Sustained Administration of Kisspeptin
Not yet reported Imperial College London 76 participants Est. completion 2027-11-30 1 siteOther conditions: Fertility Disorders, Hypothalamic DysfunctionView official trial listing → -
Recruiting NCT NCT03401047
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Not yet reported University of Virginia 37 participants Est. completion 2025-12-01 1 site Stand-aloneOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Recruiting NCT NCT03424005
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Not yet reported, Not yet reported Hoffmann-La Roche 1132 participants Est. completion 2030-09-30 55 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT03507673
Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction
University of Luebeck 1200 participants Est. completion 2028-06-30 5 sitesOther conditions: InfertilityView official trial listing → -
Recruiting NCT NCT04043520
Bioenergetic Effects of Aging and Menopause (BEAM)
Not yet reported University of Colorado, Denver 57 participants Est. completion 2024-08-31 1 siteOther conditions: Menopause, Obesity, Abdominal, Aging, Weight GainView official trial listing → -
Recruiting NCT NCT04263298
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
Not yet reported Herui Yao 210 participants Est. completion 2030-05-01 13 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT04312399
Hormone Replacement Trial Against ALzheimers' Disease
Not yet reported University Hospital, Ghent 600 participants Est. completion 2028-12-31 1 siteOther conditions: Postmenopausal Symptoms, Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT04596592
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
University of Colorado, Denver 90 participants Est. completion 2026-07-31 1 siteOther conditions: Transgenderism, Gender Dysphoria, Insulin SensitivityView official trial listing → -
Recruiting NCT NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Not yet reported Pfizer 320 participants Est. completion 2029-08-27 43 sitesOther conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung CancerView official trial listing → -
Recruiting NCT NCT04685148
Maternal Mental Health Trial
Not yet reported, Not yet reported Vibe G Frøkjær, MD, PhD 220 participants Est. completion 2030-12-31 1 siteOther conditions: Major Depressive Disorder, Postpartum DepressionView official trial listing → -
Recruiting NCT NCT05113368
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Not yet reported Sarah K. Lynam MD 31 participants Est. completion 2027-02 1 siteOther conditions: Ovarian Cancer, Serous Ovarian CancerView official trial listing → -
Recruiting NCT NCT05181033
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor
Not yet reported National University Hospital, Singapore 120 participants Est. completion 2027-08 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05216432
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Not yet reported Relay Therapeutics, Inc. 930 participants Est. completion 2027-04-30 37 sitesOther conditions: PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Solid TumorView official trial listing → -
Recruiting NCT NCT05282277
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Not yet reported University of North Carolina, Chapel Hill 103 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Depression, Psychosis, AnhedoniaView official trial listing → -
Recruiting NCT NCT05283421
Improving Diagnostics in Cervical Dysplasia
Not yet reported University of Aarhus 150 participants Est. completion 2026-08-16 1 siteOther conditions: Cervical CancerView official trial listing → -
Recruiting NCT NCT05362760
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
Not yet reported Prof. Wolfgang Janni 300 participants Est. completion 2029-04 54 sitesOther conditions: Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05394103
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Not yet reported, Not yet reported Qurient Co., Ltd. 130 participants Est. completion 2029-08-31 14 sitesOther conditions: Advanced Cancer, Metastatic CancerView official trial listing → -
Recruiting NCT NCT05472792
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Not yet reported UNC Lineberger Comprehensive Cancer Center 90 participants Est. completion 2032-04-15 1 siteOther conditions: Breast Cancer, Quality of LifeView official trial listing → -
Recruiting NCT NCT05473273
Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.
ART Fertility Clinics LLC 40 participants Est. completion 2026-12-30 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Recruiting NCT NCT05524584
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
Not yet reported University of California, Irvine 20 participants Est. completion 2031-12-31 1 siteOther conditions: Breast Cancer, Metastatic Breast Cancer, Hormone Receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05536128
Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor
Not yet reported Seoul National University Hospital 64 participants Est. completion 2025-12-31 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05573126
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
Not yet reported, Not yet reported Ellipses Pharma 95 participants Est. completion 2028-02 14 sitesOther conditions: Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05586724
Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy
Not yet reported Angelica Lindén Hirschberg 520 participants Est. completion 2027-12 1 siteOther conditions: Menopausal SymptomsView official trial listing → -
Recruiting NCT NCT05586802
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
Not yet reported Georgios Papadakis 150 participants Est. completion 2027-04-30 1 siteOther conditions: Klinefelter SyndromeView official trial listing → -
Recruiting NCT NCT05594095
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Not yet reported Fudan University 620 participants Est. completion 2026-12-01 1 siteOther conditions: Breast Neoplasm, Breast Cancer, Hormone Receptor Positive Tumor, HER2-negative Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05601440
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Not yet reported Canadian Cancer Trials Group 484 participants Est. completion 2028-06-30 10 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05608252
VS-6766+Abema+Fulv in Met HR+/HER- BC
Not yet reported, Not yet reported Adrienne G. Waks 63 participants Est. completion 2028-12-31 3 sitesOther conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast CancerView official trial listing → -
Recruiting NCT NCT05672901
Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
Not yet reported Stratpharma AG 100 participants Est. completion 2026-09 3 sitesOther conditions: Genitourinary Syndrome of MenopauseView official trial listing → -
Recruiting NCT NCT05683418
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Not yet reported Totus Medicines 241 participants Est. completion 2027-12 25 sitesOther conditions: HR+/HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05704036
Estrogen Supplementation and Bone Health in Women With CF
Not yet reported Johns Hopkins University 75 participants Est. completion 2029-01 1 site Stand-aloneOther conditions: Cystic Fibrosis, HypoestrogenismView official trial listing → -
Recruiting NCT NCT05716516
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
Not yet reported Dartmouth-Hitchcock Medical Center 36 participants Est. completion 2027-05 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05735080
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Not yet reported, Not yet reported Incyclix Bio 150 participants Est. completion 2027-09 18 sitesOther conditions: Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Ovarian Cancer, CCNE1 Amplification, Solid Tumor, Advanced Cancer, Metastatic CancerView official trial listing → -
Recruiting NCT NCT05816655
Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Not yet reported Korea University Guro Hospital 202 participants Est. completion 2029-06-30 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05899010
MIcronized PROgesterone in Frozen Embryo Transfer Cycles
Not yet reported Fundación Santiago Dexeus Font 1020 participants Est. completion 2028-04 1 siteOther conditions: InfertilityView official trial listing → -
Recruiting NCT NCT05900895
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Not yet reported Mary D Chamberlin 6 participants Est. completion 2028-12 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05982496
18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
Not yet reported Università Vita-Salute San Raffaele 119 participants Est. completion 2029-12-01 1 siteOther conditions: Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI, Axillary Lymphadenopathy, Luminal A Breast CancerView official trial listing → -
Recruiting NCT NCT06028555
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
Center for Epidemiology and Health Research, Germany 101000 participants Est. completion 2028-10-31 1 siteOther conditions: Contraception, Birth ControlView official trial listing → -
Recruiting NCT NCT06101303
Endometriosis Pain
Washington University School of Medicine 120 participants Est. completion 2029-09-01 1 siteOther conditions: Pelvic Pain, EndometriosisView official trial listing → -
Recruiting NCT NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Not yet reported Peking Union Medical College 39 participants Est. completion 2028-07-10 2 sitesOther conditions: Salivary Gland Carcinoma, Precision TherapyView official trial listing → -
Recruiting NCT NCT06208410
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
Not yet reported, Not yet reported Risen (Suzhou) Pharma Tech Co., Ltd. 306 participants Est. completion 2027-02-26 1 siteOther conditions: Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT06239376
Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients
Not yet reported Mỹ Đức Hospital 222 participants Est. completion 2027-05-30 1 siteOther conditions: Adenomyosis, IVF, Frozen Embryo TransferView official trial listing → -
Recruiting NCT NCT06280560
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
Fundación IVI 60 participants Est. completion 2026-12-30 1 siteOther conditions: Endometrial ReceptivityView official trial listing → -
Recruiting NCT NCT06307184
Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer
Instituto Valenciano de Infertilidade de Lisboa 530 participants Est. completion 2026-12 1 siteOther conditions: Frozen Embryo TransferView official trial listing → -
Recruiting NCT NCT06409390
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 15 participants Est. completion 2027-04 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06439524
The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
Not yet reported Main Line Health 110 participants Est. completion 2028-12-01 1 siteOther conditions: EndometriosisView official trial listing → -
Recruiting NCT NCT06515470
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Not yet reported Biotheryx, Inc. 82 participants Est. completion 2027-12-31 6 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06525155
Effect GnRH Agonist Administration in Endometriosis Cyst Patients
Not yet reported Rumah Sakit Pusat Angkatan Darat Gatot Soebroto 32 participants Est. completion 2025-02 1 siteOther conditions: EndometriosisView official trial listing → -
Recruiting NCT NCT06533865
Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea
Not yet reported Massachusetts General Hospital 114 participants Est. completion 2029-04 2 sites Stand-aloneOther conditions: FHA (Functional Hypothalamic Amenorrhea)View official trial listing → -
Recruiting NCT NCT06544473
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 siteOther conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen DeficiencyView official trial listing → -
Recruiting NCT NCT06570460
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 siteOther conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen DeficiencyView official trial listing → -
Recruiting NCT NCT06572930
Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
ART Fertility Clinics LLC 150 participants Est. completion 2026-12-01 1 siteOther conditions: Ovarian StimulationView official trial listing → -
Recruiting NCT NCT06607757
Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer
Not yet reported GBG Forschungs GmbH 120 participants Est. completion 2026-08-31 25 sitesOther conditions: CCCA Assessed by Ki67 Drop Below <2.7% From BaselineView official trial listing → -
Recruiting NCT NCT06610305
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
Not yet reported University of North Carolina, Chapel Hill 75 participants Est. completion 2028-06-01 1 site Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Recruiting NCT NCT06618703
Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
Not yet reported University Hospital, Angers 230 participants Est. completion 2030-10 3 sitesOther conditions: Endocrine; Deficiency, Hypothalamo-Pituitary Disorder, Radiotherapy Side EffectView official trial listing → -
Recruiting NCT NCT06625775
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Not yet reported TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) 392 participants Est. completion 2028-11 44 sitesOther conditions: Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors, HER2-positive Metastatic Breast Cancer, KRAS Mutant Metastatic Colorectal Cancer, Metastatic Lung Cancer, Metastatic Colorectal Cancer, Advanced Lung Cancer, HR-positive, HER2-negative Advanced Breast Cancer, HER2-positive Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06663072
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Not yet reported University of Chicago 25 participants Est. completion 2026-11 1 siteOther conditions: Metastatic Pancreatic Neuroendocrine TumorView official trial listing → -
Recruiting NCT NCT06726148
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Not yet reported, Not yet reported Novartis Pharmaceuticals 280 participants Est. completion 2028-09-25 33 sitesOther conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung CancerView official trial listing → -
Recruiting NCT NCT06757634
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Not yet reported Celcuity Inc 1180 participants Est. completion 2033-07-30 239 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06798571
Role of Menopause in Thermoregulation
Not yet reported Penn State University 24 participants Est. completion 2026-12-01 1 site Stand-aloneOther conditions: Menopause, AgingView official trial listing → -
Recruiting NCT NCT06806501
Muscle Mass, Quality, and the Menopause: Sex-specific Strategies to Mitigate Sarcopenia in Ageing Populations
University of Nottingham 18 participants Est. completion 2026-03 1 siteOther conditions: HealthyView official trial listing → -
Recruiting NCT NCT06851754
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 185 participants Est. completion 2031-12-31 1 siteOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Recruiting NCT NCT06852365
Combined Oral Contraceptive Pill and Resistance Starch
Not yet reported University of Pennsylvania 100 participants Est. completion 2028-04 1 siteMetabolic syndrome Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Recruiting NCT NCT06856200
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
Not yet reported Fudan University 36 participants Est. completion 2026-06 1 siteOther conditions: Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine TherapyView official trial listing → -
Recruiting NCT NCT06873971
Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause
Not yet reported University of Nove de Julho 60 participants Est. completion 2026-12-31 1 siteOther conditions: Genitourinary Syndrome of MenopauseView official trial listing → -
Recruiting NCT NCT06896617
Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)
Not yet reported Fundacion Clinic per a la Recerca Biomédica 334 participants Est. completion 2026-12-20 1 siteOther conditions: Infertilities, Embryo TransferView official trial listing → -
Recruiting NCT NCT06905210
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
Not yet reported Eurofarma Laboratorios S.A. 531 participants Est. completion 2027-03 18 sitesOther conditions: Acne Vulgaris, Acne Vulgaris on the FaceView official trial listing → -
Recruiting NCT NCT06936930
Reproductive and Mental Health of Patients With Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 600 participants Est. completion 2027-12-31 1 siteOther conditions: Aplastic Anemia, Reproductive HealthView official trial listing → -
Recruiting NCT NCT06953076
Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 111 participants Est. completion 2027-05-02 1 siteOther conditions: Uterine Bleeding, Uterine Leiomyomas, Uterine Hemorrhage, Uterine NeoplasmsView official trial listing → -
Recruiting NCT NCT06969326
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
Not yet reported Women and Infants Hospital of Rhode Island 48 participants Est. completion 2026-12-01 1 siteOther conditions: Postoperative Bleeding, Gender Dysphoria, HysterectomyView official trial listing → -
Recruiting NCT NCT06979596
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sitesOther conditions: Malignant NeoplasmView official trial listing → -
Recruiting NCT NCT06982521
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Not yet reported Relay Therapeutics, Inc. 540 participants Est. completion 2031-12-31 254 sitesOther conditions: PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer, Metastatic Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06993844
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Not yet reported, Not yet reported Ensem Therapeutics 233 participants Est. completion 2027-12-30 15 sitesOther conditions: Advanced Solid Tumors, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06995482
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers
Not yet reported Kashiv BioSciences, LLC 40 participants Est. completion 2026-06 2 sitesOther conditions: Healthy Postmenopausal WomenView official trial listing → -
Recruiting NCT NCT06997029
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Not yet reported Bristol-Myers Squibb 234 participants Est. completion 2028-12-14 21 sitesOther conditions: Advanced Solid Tumor, Advanced Breast Cancer, Advanced Ovarian CancerView official trial listing → -
Recruiting NCT NCT06998108
Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy
Not yet reported BeBetter Med Inc 330 participants Est. completion 2026-06-30 1 siteOther conditions: HR+/HER2- Locally Advanced, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06998407
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 380 participants Est. completion 2030-08 16 sitesOther conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07015476
Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea
IRCCS Azienda Ospedaliero-Universitaria di Bologna 180 participants Est. completion 2026-11 1 siteOther conditions: AmenorrheaView official trial listing → -
Recruiting NCT NCT07024173
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Not yet reported Shandong Suncadia Medicine Co., Ltd. 240 participants Est. completion 2027-12 2 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07037082
Understanding Cycles to Improve Women's Health
University Hospital, Montpellier 320 participants Est. completion 2029-07-01 1 siteOther conditions: Woman of Reproductive Age, Socioeconomic FactorsView official trial listing → -
Recruiting NCT NCT07109726
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Not yet reported, Not yet reported Terremoto Biosciences Inc. 248 participants Est. completion 2029-02-28 25 sitesOther conditions: Breast Cancer, Endometrial Cancer, Ovarian Cancer, Lung Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Solid Tumor, Cervical CancerView official trial listing → -
Recruiting NCT NCT07115082
Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
Not yet reported, Not yet reported Yan Hongli 50 participants Est. completion 2026-03-30 1 siteOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Recruiting NCT NCT07117630
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
Not yet reported Fudan University 60 participants Est. completion 2027-12 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07148921
Perception of Pain During Gender Affirming Hormone Therapy
Medical University of Vienna 40 participants Est. completion 2026-03 1 siteOther conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex HormonesView official trial listing → -
Recruiting NCT NCT07180160
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
Not yet reported Wenjin Yin 123 participants Est. completion 2028-03 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07187947
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500 participants Est. completion 2035-12-31 1 siteCardiovascular disease Other conditions: Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Health StatusView official trial listing → -
Recruiting NCT NCT07254429
COMPASS - COpenhagen MenoPAuSe Study
Not yet reported Martin Blomberg Jensen 192 participants Est. completion 2028-05 1 siteOther conditions: Menopausal Osteoporosis, Bone MarkersView official trial listing → -
Recruiting NCT NCT07287917
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Not yet reported, Not yet reported Aminex Therapeutics, Inc. 92 participants Est. completion 2028-12-29 20 sitesOther conditions: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast CancerView official trial listing → -
Recruiting NCT NCT07330544
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
Not yet reported Zhejiang Cancer Hospital 118 participants Est. completion 2028-11-26 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07339722
A Study of LY4515100 in Healthy Participants
Not yet reported Eli Lilly and Company 209 participants Est. completion 2027-03 2 sitesOther conditions: HealthyView official trial listing → -
Recruiting NCT NCT07340190
A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2028-04-07 6 sitesOther conditions: Advanced MalignanciesView official trial listing → -
Recruiting NCT NCT07347600
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 500 participants Est. completion 2029-12-31 32 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07358468
Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study
Mỹ Đức Hospital 384 participants Est. completion 2027-12-01 2 sitesOther conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine PeristalsisView official trial listing → -
Recruiting NCT NCT07368998
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
Not yet reported Hoffmann-La Roche 80 participants Est. completion 2031-10-31 34 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07389733
A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer
Not yet reported, Not yet reported Shandong Suncadia Medicine Co., Ltd. 180 participants Est. completion 2028-12 2 sitesOther conditions: Advanced Unresectable or Metastatic Breast Cancer of AdultsView official trial listing → -
Recruiting NCT NCT07405801
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Not yet reported Hoffmann-La Roche 80 participants Est. completion 2030-02-26 59 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07421895
A Prospective Multicenter Observational Real-world Study of Retained Products of Conception
The Third Xiangya Hospital of Central South University 600 participants Est. completion 2032-12-31 1 siteOther conditions: Retained Products of Conception, RPOCView official trial listing → -
Recruiting NCT NCT07422506
A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion
Not yet reported The Third Xiangya Hospital of Central South University 580 participants Est. completion 2035-01-01 1 siteOther conditions: Missed Abortion, Early Pregnancy FailureView official trial listing → -
Recruiting NCT NCT07426822
Rash & Diarrhea Prophylaxis With Capivasertib
Not yet reported Maryam Lustberg 108 participants Est. completion 2029-04 1 siteOther conditions: Metastatic HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07499804
Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Not yet reported Beni-Suef University 100 participants Est. completion 2026-04-30 1 siteOther conditions: IVF, Infertility, FemaleView official trial listing → -
Recruiting NCT NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Not yet reported IDEAYA Biosciences 155 participants Est. completion 2030-01-31 23 sitesOther conditions: CancerView official trial listing → -
Recruiting NCT NCT07558733
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Not yet reported, Not yet reported Faeth Therapeutics 32 participants Est. completion 2033-05 9 sitesOther conditions: HR+ HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07580950
The Research of Integrated Traditional Chinese and Western Medicine on Hypothalamic Amenorrhea
Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2028-06-30 1 siteOther conditions: Functional Hypothalamic AmenorrheaView official trial listing → -
Recruiting NCT NCT07666555
A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.
Not yet reported Fudan University 98 participants Est. completion 2029-12-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07675213
Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles
Mỹ Đức Hospital 442 participants Est. completion 2027-12-01 1 siteOther conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis, Hormone Replacement Therapy (HRT)View official trial listing → -
Recruiting NCT NCT07704658
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Not yet reported Rigel Pharmaceuticals 12 participants Est. completion 2027-08-30 2 sitesOther conditions: NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies, Advanced MalignanciesView official trial listing → -
Recruiting NCT NCT07792408
Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives
Not yet reported Vertex Pharmaceuticals Incorporated 148 participants Est. completion 2027-03-20 1 siteOther conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)View official trial listing → -
Recruiting NCT NCT07794150
A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects
Not yet reported Corium Innovations, Inc. 250 participants Est. completion 2027-05-31 2 sitesOther conditions: Menopause, Healthy Female ParticipantsView official trial listing → -
Recruiting NCT NCT07808060
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
Not yet reported Eli Lilly and Company 34 participants Est. completion 2027-06 2 sitesOther conditions: Obesity, OverweightView official trial listing → -
Recruiting NCT NCT07831499
Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health
Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-07-15 1 site Stand-aloneOther conditions: Menopause, Healthy Adult, Brain, PostmenopausalView official trial listing → -
Recruiting NCT NCT07923214
A Phase I Dose Escalation Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors
Not yet reported Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. 66 participants Est. completion 2027-12 4 sitesOther conditions: Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid TumorsView official trial listing → -
Completed NCT NCT00000466
Postmenopausal Estrogen/Progestin Interventions (PEPI)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-10Cardiovascular disease Other conditions: Bone Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia, Osteoporosis, Thrombosis, PostmenopauseView official trial listing → -
Completed NCT NCT00000555
Women's Angiographic Vitamin and Estrogen Trial (WAVE)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-05Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, PostmenopauseView official trial listing → -
Completed NCT NCT00000559
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2001-08Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial Ischemia, PostmenopauseView official trial listing → -
Completed NCT NCT00000897
A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 42 participants 6 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00001221
Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 160 participants Est. completion 2003-09 1 siteOther conditions: Gonadal Dysgenesis, Turner's SyndromeView official trial listing → -
Completed NCT NCT00001259
A Treatment Study for Premenstrual Syndrome (PMS)
Not yet reported National Institute of Mental Health (NIMH) 60 participants Est. completion 2020-02-06 1 site Stand-aloneOther conditions: Premenstrual Syndrome, Menstruation DisturbancesView official trial listing → -
Completed NCT NCT00002721
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Not yet reported University of New Mexico 18 participants Est. completion 2013-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00003066
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
Not yet reported Herbert Irving Comprehensive Cancer Center 40 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003084
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 75 participants Est. completion 2002-11 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003394
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2003-04 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003584
Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
Not yet reported University of New Mexico 35 participants Est. completion 2000-12 1 siteOther conditions: Kidney CancerView official trial listing → -
Status unknown NCT NCT00003633
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Not yet reported Herbert Irving Comprehensive Cancer Center 12 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00003717
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Not yet reported St. Barnabas Medical Center 17 participants 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00004054
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 397 participants Est. completion 2013-11 54 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005048
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported NYU Langone Health 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005108
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-01 1 siteOther conditions: Atherosclerosis, Healthy, Vascular DiseaseView official trial listing → -
Completed NCT NCT00005627
Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Dana-Farber Cancer Institute Est. completion 2003-04 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005810
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Alliance for Clinical Trials in Oncology 40 participants Est. completion 2006-06 7 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005847
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Eastern Cooperative Oncology Group 19 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00006133
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Not yet reported National Center for Research Resources (NCRR) 970 participants 17 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Terminated NCT NCT00010153
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00014352
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 1 siteOther conditions: Prostate Cancer, ThromboembolismView official trial listing → -
Completed NCT NCT00016107
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
Not yet reported National Cancer Institute (NCI) 72 participants 1 siteOther conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Terminated NCT NCT00024167
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 265 participants 40 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00028769
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2011-07 91 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00029159
The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
Not yet reported Thomas Jefferson University 200 participants Est. completion 2012-06 2 sitesOther conditions: Turner SyndromeView official trial listing → -
Completed NCT NCT00029757
Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women
Not yet reported National Center for Research Resources (NCRR) 15 participants 1 siteOther conditions: Menopause, PostmenopauseView official trial listing → -
Completed NCT NCT00030095
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Not yet reported National Cancer Institute (NCI) 2 sitesOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00030147
Raloxifene and Rimostil for Perimenopause-Related Depression
Not yet reported National Institute of Mental Health (NIMH) 65 participants Est. completion 2015-06 1 siteOther conditions: Perimenopausal Depression, DepressionView official trial listing → -
Completed NCT NCT00033358
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Not yet reported National Cancer Institute (NCI) 52 participants 1 siteOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT00038246
Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
Not yet reported, Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2004-12 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00056901
Screening Evaluation for Women With Postpartum Depression
National Institute of Mental Health (NIMH) 68 participants Est. completion 2017-12-24 1 siteOther conditions: Postpartum Depression, DepressionView official trial listing → -
Completed NCT NCT00057941
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 148 participants Est. completion 2012-06 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT00060736
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
National Institute of Mental Health (NIMH) 60 participants Est. completion 2016-04-27 1 siteOther conditions: Perimenopausal Depression, Post Menopausal, Healthy, DepressionView official trial listing → -
Completed NCT NCT00065325
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Not yet reported AstraZeneca 694 participants Est. completion 2014-09 117 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00066157
Alzheimer's Disease: Therapeutic Potential of Estrogen
Not yet reported, Not yet reported University of Wisconsin, Madison 42 participants Est. completion 2007-12 1 site Stand-aloneOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT00075764
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
Not yet reported SWOG Cancer Research Network 695 participants Est. completion 2018-10-01 426 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00079248
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
Not yet reported Institute of Cancer Research, United Kingdom 1 siteOther conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms, OsteoporosisView official trial listing → -
Completed NCT NCT00082810
Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 33 participants Est. completion 2008-09 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT00083824
Estrogen, HDL, and Coronary Heart Disease in Women
Not yet reported, Not yet reported Tufts University 309 participants Est. completion 2007-02 1 siteCardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Coronary ArteriosclerosisView official trial listing → -
Terminated NCT NCT00089414
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
Not yet reported National Institute of Mental Health (NIMH) 5 participants Est. completion 2010-06 1 siteOther conditions: Premenstrual Syndrome, PMS, Premenstrual Dysphoric Disorder, PMDD, DepressionView official trial listing → -
Completed NCT NCT00090857
Letrozole in Preventing Breast Cancer in Postmenopausal Women
Not yet reported Dana-Farber Cancer Institute 49 participants Est. completion 2013-03 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00093002
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Not yet reported AstraZeneca 179 participants Est. completion 2007-07 31 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00100854
Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Not yet reported Translational Oncology Research International 108 participants Est. completion 2018-09-05 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00108238
Estrogen Alternatives Study
Not yet reported US Department of Veterans Affairs Est. completion 2006-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00108849
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Not yet reported Novo Nordisk A/S 309 participants Est. completion 2007-05 57 sitesOther conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Completed NCT NCT00113100
Mechanisms of Skin Repair by Topical Estrogen
Not yet reported University of Michigan 152 participants Est. completion 2007-06 1 siteOther conditions: Skin WrinklingView official trial listing → -
Withdrawn NCT NCT00117260
Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
Not yet reported Duramed Research Est. completion 2007-08Other conditions: OsteopeniaView official trial listing → -
Terminated NCT NCT00123539
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 334 participants Est. completion 2005-08 1 siteCardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Neurologic ManifestationsView official trial listing → -
Terminated NCT NCT00131924
High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Not yet reported Northwestern University 1 participants Est. completion 2006-01 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00138125
Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer
Not yet reported Translational Oncology Research International 2 participants Est. completion 2009-12 3 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00141544
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 28 participants Est. completion 2008-03 78 sitesOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT00141557
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 133 participants Est. completion 2008-03 78 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00145522
Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 135 participants Est. completion 2009-03 11 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00151060
Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2006-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00151073
Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2007-09 1 siteOther conditions: Hormone-Refractory Prostate CancerView official trial listing → -
Completed NCT NCT00151086
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 33 participants Est. completion 2006-08 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00152282
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
Not yet reported Abbott 105 participants Est. completion 2001-08Other conditions: Amenorrhea, PostmenopauseView official trial listing → -
Completed NCT NCT00160316
Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
Not yet reported Solvay Pharmaceuticals 454 participants Est. completion 2007-12 22 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00160342
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Not yet reported Solvay Pharmaceuticals 1251 participants Est. completion 2007-09 125 sitesOther conditions: Hot Flushes, Menopause, PostmenopauseView official trial listing → -
Completed NCT NCT00161681
Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-08 48 sitesOther conditions: Premenstrual SyndromeView official trial listing → -
Completed NCT NCT00163033
Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women
Not yet reported Pantarhei Bioscience 49 participants Est. completion 2007-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00165399
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
Not yet reported Dana-Farber Cancer Institute 62 participants Est. completion 2005-12-31 5 sitesOther conditions: Adenocarcinoma of the Prostate, Prostate CancerView official trial listing → -
Completed NCT NCT00167921
Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants 2 sitesOther conditions: Atrophic VaginitisView official trial listing → -
Terminated NCT NCT00176527
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Not yet reported University of Medicine and Dentistry of New Jersey 40 participants Est. completion 2007-08 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00176644
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
Not yet reported University of Medicine and Dentistry of New Jersey 23 participants Est. completion 2008-12 6 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00179426
Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
Beth Israel Deaconess Medical Center 175 participants Est. completion 2006-06 1 siteOther conditions: Seizure Disorder, EpilepsyView official trial listing → -
Completed NCT NCT00183924
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
Not yet reported University of Southern California 20 participants Est. completion 2008-12 1 siteOther conditions: Prostate AdenocarcinomaView official trial listing → -
Terminated NCT NCT00183963
A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
Not yet reported University of Southern California 4 participants Est. completion 2008-06 1 siteOther conditions: Breast CarcinomaView official trial listing → -
Completed NCT NCT00184795
Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations
Not yet reported Novo Nordisk A/S 576 participants Est. completion 2005-05-04 91 sitesOther conditions: Menopause, Menopausal Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00185224
Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive
Not yet reported Bayer 58 participants Est. completion 2006-03 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00185237
Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch
Not yet reported Bayer 165 participants Est. completion 2006-11Other conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00185328
Efficacy and Tolerability of Angeliq in Thai Women
Not yet reported Bayer 55 participants Est. completion 2006-12Other conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00191113
Somatropin Treatment to Final Height in Turner Syndrome
Not yet reported Eli Lilly and Company 154 participants Est. completion 2007-12 14 sitesOther conditions: Turner SyndromeView official trial listing → -
Completed NCT NCT00193193
Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma
Not yet reported SCRI Development Innovations, LLC 100 participants Est. completion 2007-02Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00193271
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
Not yet reported SCRI Development Innovations, LLC 30 participants Est. completion 2007-05 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00193726
Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer
Not yet reported Sudeep Gupta 273 participants Est. completion 2012-03-30 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00195455
Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 133 participants Est. completion 2007-03 6 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00195559
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 526 participants Est. completion 2007-12 51 sitesOther conditions: Premenstrual Syndrome, Menstruation DisturbancesView official trial listing → -
Completed NCT NCT00196326
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
Not yet reported Duramed Research 2235 participants Est. completion 2007-06 55 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00196365
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Not yet reported Duramed Research 97 participants Est. completion 2007-07 18 sitesOther conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00201864
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2014-02 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00204074
Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
Not yet reported, Not yet reported University Hospital, Linkoeping Est. completion 2005-07 1 siteOther conditions: MigraineView official trial listing → -
Terminated NCT NCT00206414
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer
Not yet reported Baylor Breast Care Center 15 participants Est. completion 2006-09 1 siteOther conditions: BREAST CANCERView official trial listing → -
Completed NCT NCT00206557
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
Not yet reported The Alfred 60 participants Est. completion 2007-04 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00206570
Clinical Estradiol Trial in Women With Schizophrenia
Not yet reported Bayside Health 100 participants Est. completion 2004-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00206622
Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes
Not yet reported Bayer 425 participants Est. completion 2006-02 45 sitesOther conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00212277
Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.
Not yet reported Nobelpharma Est. completion 2007-02Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00213096
Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive
Not yet reported Population Council 50 participants Est. completion 2004-02 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00224094
A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women
Not yet reported Watson Pharmaceuticals 27 participants 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00227942
Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia
Not yet reported Hadine Joffe, MD 86 participants Est. completion 2007-11 1 siteOther conditions: Sleep Initiation and Maintenance Disorders, DepressionView official trial listing → -
Completed NCT NCT00230815
A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction
Not yet reported EMD Serono 62 participants Est. completion 2005-11Other conditions: InfertilityView official trial listing → -
Completed NCT NCT00234819
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 325 participants Est. completion 2007-02 7 sitesOther conditions: Vasomotor Symptoms Associated With MenopauseView official trial listing → -
Terminated NCT NCT00236301
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2007-01 1 siteOther conditions: Healthy Symptomatic Menopausal WomenView official trial listing → -
Completed NCT NCT00236769
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1751 participants Est. completion 1999-10Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00236782
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1517 participants Est. completion 1999-03Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00236795
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1494 participants Est. completion 1999-03Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00241449
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
Not yet reported AstraZeneca 51 participants Est. completion 2012-01 139 sitesOther conditions: Breast Cancer, MetastasisView official trial listing → -
Completed NCT NCT00253422
Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors
Not yet reported Institute of Cancer Research, United Kingdom 698 participants Est. completion 2022-11-28 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00254189
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2004-10Other conditions: OvulationView official trial listing → -
Completed NCT NCT00254800
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
Not yet reported AstraZeneca 38 participants Est. completion 2006-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00258063
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 2004-09Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00258076
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2004-09Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00259090
Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
Not yet reported AstraZeneca 120 participants Est. completion 2008-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00264407
Neural Changes in the Aging Auditory System
University of Rochester 126 participants Est. completion 2005-02 2 sitesAlcohol use disorder Other conditions: Progesterone, Estrogens, Hearing, PsychoacousticsView official trial listing → -
Completed NCT NCT00272740
SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer
Not yet reported AstraZeneca 93 participants 8 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00274469
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
Not yet reported AstraZeneca 205 participants Est. completion 2017-01-13 41 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00283816
Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy
Not yet reported University of Rochester 36 participants Est. completion 2008-01 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00293059
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Not yet reported Bayer 190 participants Est. completion 2008-05 46 sitesOther conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00298025
A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
Not yet reported EMD Serono 185 participants Est. completion 2004-05Other conditions: Infertile Women Undergoing Assisted Reproductive Technology (ART)View official trial listing → -
Terminated NCT NCT00302731
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
Not yet reported Jeanne Drisko, MD, CNS, FACN 21 participants Est. completion 2014-09 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00303524
Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients
Not yet reported AstraZeneca 170 participants Est. completion 2009-02 22 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00305448
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
Not yet reported AstraZeneca 143 participants Est. completion 2012-02 35 sitesOther conditions: Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT00307775
Vaginal Estrogen for the Treatment of Faecal Incontinence in Women
Not yet reported London North West Healthcare NHS Trust 43 participants Est. completion 2011-10 1 siteOther conditions: Fecal IncontinenceView official trial listing → -
Completed NCT NCT00307801
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Not yet reported Bayer 231 participants Est. completion 2008-05 36 sitesOther conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00310531
3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
Not yet reported Bayer 500 participants Est. completion 2007-06Other conditions: OsteopeniaView official trial listing → -
Completed NCT NCT00318318
Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20 participants Est. completion 2007-02 1 siteOther conditions: Healthy, Estrogen Replacement TherapyView official trial listing → -
Completed NCT NCT00319163
Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 26 participants Est. completion 2006-11 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00320567
The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa
Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 123 participants Est. completion 2004-04Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00320580
An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 239 participants Est. completion 2003-03Other conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00324259
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported Washington University School of Medicine 66 participants Est. completion 2014-08 7 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00327769
Faslodex Advanced Breast Cancer Local Chinese Study
Not yet reported AstraZeneca 234 participants Est. completion 2007-09 12 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00328120
Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
Not yet reported AstraZeneca 20 participants Est. completion 2010-06 5 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00328497
A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
Not yet reported CASI pharmaceuticals, Inc. 31 participants Est. completion 2009-12 1 siteOther conditions: Carcinoid TumorView official trial listing → -
Completed NCT NCT00331071
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 334 participants Est. completion 2006-03Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00334295
Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.
Not yet reported AstraZeneca 35 participants Est. completion 2011-01 9 sitesOther conditions: Endometrial CarcinomaView official trial listing → -
Status unknown NCT NCT00334971
Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women
Not yet reported Massachusetts General Hospital 116 participants Est. completion 2018-01 1 siteOther conditions: Healthy, Fragile X SyndromeView official trial listing → -
Completed NCT NCT00335218
Fat Distribution in Healthy Early Postmenopausal Women
Not yet reported Bayer 67 participants Est. completion 2004-08 3 sitesOther conditions: Healthy, PostmenopauseView official trial listing → -
Completed NCT NCT00338052
Study of Bleeding With Extended Administration of an Oral Contraceptive
Not yet reported Warner Chilcott 207 participants Est. completion 2007-05 23 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00344383
An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 61 participants Est. completion 2004-07Other conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00356447
Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Not yet reported Bayer 249 participants Est. completion 2007-10 9 sitesOther conditions: Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00357006
A Definitive Estrogen Patch Study (ADEPT)
Not yet reported The Alfred 180 participants Est. completion 2013-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)View official trial listing → -
Completed NCT NCT00357110
Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
Not yet reported AstraZeneca 13 participants Est. completion 2008-10 25 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00361075
Midlife Cholesterol Study
Not yet reported Northwestern University 120 participants Est. completion 2005-05 2 sitesCardiovascular disease Other conditions: Menopause, Postmenopause, PremenopauseView official trial listing → -
Withdrawn NCT NCT00370019
Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Est. completion 2011-12-12 1 siteOther conditions: Premature Ovarian FailureView official trial listing → -
Terminated NCT NCT00372996
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Not yet reported Pfizer 219 participants Est. completion 2014-06 62 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00377988
A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 423 participants Est. completion 2008-10Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00380887
Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women
Wyeth is now a wholly owned subsidiary of Pfizer 54 participantsOther conditions: PostmenopauseView official trial listing → -
Terminated NCT NCT00387829
DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery
Not yet reported Integra LifeSciences Corporation 347 participants Est. completion 2011-12 36 sitesOther conditions: Spinal Injuries, AdhesionsView official trial listing → -
Completed NCT NCT00390455
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Not yet reported National Cancer Institute (NCI) 295 participants Est. completion 2014-07-02 368 sitesOther conditions: Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT00391417
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
Not yet reported BioSante Pharmaceuticals 431 participants Est. completion 2005-04Other conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00391807
Study of Safety and Efficacy of an Oral Contraceptive
Not yet reported Warner Chilcott 1683 participants Est. completion 2008-09 66 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00396799
Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2006-11Other conditions: MenopauseView official trial listing → -
Completed NCT NCT00399685
Drug Interaction - Oral Contraceptive
Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2007-08 2 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00401219
Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-02Other conditions: Estrogen Replacement TherapyView official trial listing → -
Completed NCT NCT00402636
Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)
Not yet reported Deutsches Herzzentrum Muenchen 502 participants Est. completion 2006-10 2 sitesOther conditions: Coronary Heart DiseaseView official trial listing → -
Withdrawn NCT NCT00402935
Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer
Case Comprehensive Cancer Center Est. completion 2007-05 1 siteOther conditions: Leukemia, Long-term Effects Secondary to Cancer Therapy in Adults, Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma, Sexual Dysfunction and Infertility, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00413764
Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)
Not yet reported Organon and Co 358 participants Est. completion 2005-11-15Other conditions: Sexual DysfunctionView official trial listing → -
Completed NCT NCT00423917
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2017-01-15 205 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00425776
Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture
Not yet reported Vejle Hospital 94 participants Est. completion 2010-01 1 siteOther conditions: Breast Cancer, PostmenopauseView official trial listing → -
Completed NCT NCT00426972
Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites
Not yet reported Renovo 148 participants Est. completion 2008-10 30 sitesOther conditions: Burn, Trauma, Varicose UlcerView official trial listing → -
Completed NCT NCT00431093
Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)
Not yet reported Organon and Co 570 participants Est. completion 2005-03Other conditions: MenopauseView official trial listing → -
Completed NCT NCT00442689
Metabolic Syndrome in PCOS: Precursors and Interventions
Not yet reported Northwestern University 97 participants Est. completion 2012-11 1 siteMetabolic syndrome Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Withdrawn NCT NCT00447863
Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-08Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00451555
Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
Not yet reported Eli Lilly and Company 156 participants Est. completion 2018-10-18 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00455156
Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring
Not yet reported Premier Research 1200 participants Est. completion 2011-09 15 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00455962
Effect of Race on Gonadotropin Responses
Not yet reported, Not yet reported Massachusetts General Hospital 23 participants Est. completion 2011-12 1 siteOther conditions: Premenopause, HealthyView official trial listing → -
Completed NCT NCT00464789
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-05Other conditions: MenopauseView official trial listing → -
Completed NCT NCT00465192
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
Not yet reported Novo Nordisk A/S 230 participants Est. completion 1995-11-30Other conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Completed NCT NCT00471991
Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
Not yet reported Bayer 60 participants Est. completion 2007-12 1 siteOther conditions: Oral ContraceptiveView official trial listing → -
Completed NCT NCT00472004
Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 204 participants Est. completion 2009-12 1 siteOther conditions: Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00475553
Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®
Not yet reported Scott and White Hospital & Clinic 75 participants Est. completion 2008-05 1 siteOther conditions: Breakthrough Bleeding, Breakthrough SpottingView official trial listing → -
Completed NCT NCT00477633
Study of Safety and Efficacy of an Oral Contraceptive
Not yet reported Warner Chilcott 1700 participants Est. completion 2009-02 63 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00479778
Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 72 participants Est. completion 2007-07 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00480532
A Study of Continuous Oral Contraceptives and Doxycycline
Not yet reported Oregon Health and Science University 131 participants Est. completion 2011-05 2 sitesOther conditions: Contraceptives, OralView official trial listing → -
Completed NCT NCT00481455
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
Not yet reported CASI pharmaceuticals, Inc. 15 participants Est. completion 2008-10 1 siteOther conditions: Recurrent Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT00484107
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women
Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-10Other conditions: PostmenopauseView official trial listing → -
Status unknown NCT NCT00490308
The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment
Not yet reported Assaf-Harofeh Medical Center 120 participants Est. completion 2008-08 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00504816
A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers
Not yet reported GlaxoSmithKline 22 participants Est. completion 2008-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00511199
Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)
Not yet reported Organon and Co 2152 participants Est. completion 2008-04-01Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00511342
Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)
Not yet reported Organon and Co 110 participants Est. completion 2009-06Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00511355
Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)
Not yet reported Organon and Co 121 participants Est. completion 2008-01Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00511433
Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)
Not yet reported Organon and Co 48 participants Est. completion 2008-01Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00534417
Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported Accelerated Community Oncology Research Network 41 participants Est. completion 2011-09 10 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00541281
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150 participants Est. completion 2006-02 19 sitesOther conditions: Hormone Resistant Prostate Cancer, Metastatic Prostate CancerView official trial listing → -
Terminated NCT NCT00543127
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
Not yet reported Spanish Breast Cancer Research Group 870 participants Est. completion 2016-07 53 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00549666
A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
Not yet reported Sumitomo Pharma America, Inc. 23 participants Est. completion 2007-12 1 siteOther conditions: PharmacokineticsView official trial listing → -
Terminated NCT NCT00551733
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Not yet reported CTI BioPharma 450 participants Est. completion 2007-12-25 41 sitesOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00554632
Birth Control Pill vs Birth Control Patch Study
Not yet reported University of Vermont 24 participants Est. completion 2005-08Other conditions: Venous ThrombosisView official trial listing → -
Completed NCT NCT00563576
Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation
Not yet reported Columbia University 71 participants Est. completion 2009-02 1 siteOther conditions: MetrorrhagiaView official trial listing → -
Terminated NCT NCT00565916
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
Not yet reported Washington University School of Medicine 22 participants Est. completion 2008-01 1 siteOther conditions: Postmenopausal SyndromeView official trial listing → -
Completed NCT NCT00569244
SH T00186 in the Treatment of Primary Dysmenorrhea
Not yet reported Bayer 223 participants Est. completion 2009-12 27 sitesOther conditions: Primary DysmenorrheaView official trial listing → -
Terminated NCT NCT00570258
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Not yet reported University of Arkansas 27 participants Est. completion 2017-12 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00570921
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Not yet reported Mara Chambers 33 participants Est. completion 2015-01 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00576225
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
Not yet reported CTI BioPharma Est. completion 2010-04-05 44 sitesOther conditions: NSCLCView official trial listing → -
Completed NCT NCT00586898
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Not yet reported Memorial Sloan Kettering Cancer Center 36 participants Est. completion 2009-03 1 siteOther conditions: Prostate, Cancer, Hormonal CyclingView official trial listing → -
Completed NCT NCT00589134
The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
Not yet reported Yale University 26 participants Est. completion 2009-12 1 siteOther conditions: Exercise Induced HyponatremiaView official trial listing → -
Terminated NCT NCT00592007
Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer
Not yet reported Lyudmila Bazhenova, M.D. 7 participants Est. completion 2012-04 1 siteOther conditions: Non Small Cell Lung CarcinomaView official trial listing → -
Completed NCT NCT00604825
Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)
Not yet reported GlaxoSmithKline 356 participants Est. completion 2008-07-23 87 sitesOther conditions: Menopausal and Female Climacteric StatesView official trial listing → -
Status unknown NCT NCT00617500
Climacteric Clinical Trial : the Use of Complementary Therapy and Hormonal Replacement
Not yet reported Sociedade Hospital Samaritano 278 participants Est. completion 2009-11 2 sitesOther conditions: ClimactericView official trial listing → -
Completed NCT NCT00619866
An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis
Not yet reported AbbVie 155 participants Est. completion 2009-08-28Other conditions: Endometriosis, PainView official trial listing → -
Status unknown NCT NCT00623116
A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland
Not yet reported Hospital for Children and Adolescents, Finland 50 participants Est. completion 2025-12 1 siteOther conditions: Kallmann SyndromeView official trial listing → -
Completed NCT NCT00629616
Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer
Not yet reported UNICANCER 116 participants Est. completion 2018-04 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00631124
A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
Not yet reported Bayer 103 participants Est. completion 2008-12 2 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00635713
Second Line Breast Cancer Trial
Not yet reported AstraZeneca 588 participants Est. completion 2004-09Other conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00640224
Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
Not yet reported Silva Arslanian 65 participants Est. completion 2015-07 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00649896
Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day
Not yet reported Mylan Pharmaceuticals Inc 76 participants Est. completion 2003-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00651469
Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.
Not yet reported Bayer 534 participants Est. completion 2004-07 27 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT00651599
Treatment of Vasomotor Symptoms in Korean Post Menopausal Women
Not yet reported Bayer 90 participants Est. completion 2005-05 4 sitesOther conditions: Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00653016
An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method
Not yet reported Janssen-Ortho Inc., Canada 405 participants Est. completion 2003-08Other conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT00653614
Cycle Control and Safety of E2-DRSP
Not yet reported Bayer 635 participants Est. completion 2009-06 25 sitesOther conditions: Contraceptive, Oral, HormonalView official trial listing → -
Completed NCT NCT00660803
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
AstraZeneca 200 participants Est. completion 2009-04 4 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00661531
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Not yet reported Georgetown University 11 participants Est. completion 2015-06 3 sitesOther conditions: Breast Cancer, Cancer of the Breast, Neoplasms, BreastView official trial listing → -
Completed NCT NCT00662454
Oral Contraceptive Efficacy and Body Weight
Not yet reported Oregon Health and Science University 120 participants Est. completion 2006-05 1 siteOther conditions: Contraception, Body WeightView official trial listing → -
Completed NCT NCT00668603
Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
Not yet reported University of Helsinki 160 participants Est. completion 2008-03 1 siteCardiovascular disease Other conditions: Postmenopausal Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00685009
The Women's Health Initiative Memory Study (The WHIMS Study)
National Heart, Lung, and Blood Institute (NHLBI) 7525 participants Est. completion 2008-03 1 siteOther conditions: Dementia SyndromesView official trial listing → -
Status unknown NCT NCT00688194
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
Not yet reported Gruppo Italiano Mammella (GIM) 396 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00697307
Bioequivalence Study of Patches With Different Release Profiles
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 43 participants Est. completion 2003-07Other conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT00698035
Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients
Not yet reported University of California, San Francisco 76 participants Est. completion 2012-12 1 siteOther conditions: Sexual Dysfunction, PhysiologicalView official trial listing → -
Terminated NCT NCT00705822
Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
Not yet reported Sanofi 54 participants Est. completion 2009-07 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT00706225
Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-07 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00709189
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2005-08Other conditions: Female Contraception, Contraception, Therapeutic Equivalency, PharmacokineticsView official trial listing → -
Completed NCT NCT00709644
Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2005-08Other conditions: Pharmacokinetics, Therapeutic Equivalency, Contraceptives, OralView official trial listing → -
Completed NCT NCT00709982
A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-07Other conditions: Drug Interactions, Healthy, PharmacokineticsView official trial listing → -
Terminated NCT NCT00722072
Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy
Not yet reported OHSU Knight Cancer Institute 12 participants Est. completion 2012-07 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00722761
Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
Not yet reported Massachusetts General Hospital 30 participants Est. completion 2012-04 1 siteOther conditions: Acne VulgarisView official trial listing → -
Terminated NCT NCT00722800
A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
Not yet reported Massachusetts General Hospital 4 participants Est. completion 2011-12 1 siteOther conditions: Hidradenitis SuppurativaView official trial listing → -
Completed NCT NCT00728949
A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
Not yet reported Eli Lilly and Company 93 participants Est. completion 2015-02 9 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT00729404
Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene
Not yet reported Bayer 17 participants Est. completion 2009-02 3 sitesOther conditions: Contraception, Ovulation InhibitionView official trial listing → -
Completed NCT NCT00740025
Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)
Virginia Center for Reproductive Medicine 200 participants Est. completion 2010-01 1 siteOther conditions: PregnancyView official trial listing → -
Completed NCT NCT00741858
Duragen Versus Duraguard in Chiari Surgery
Not yet reported University of Illinois Chicago 34 participants Est. completion 2010-04 1 siteOther conditions: Chiari MalformationView official trial listing → -
Terminated NCT NCT00744328
Postpartum Depression: Transdermal Estradiol Versus Sertraline
Not yet reported Northwestern University 85 participants Est. completion 2013-09 1 site Stand-aloneOther conditions: Postpartum DepressionView official trial listing → -
Completed NCT NCT00745108
Tibolone Endometrium Study (Study 32972)(P06470)
Not yet reported Organon and Co 32 participants Est. completion 2005-07-21Other conditions: Postmenopausal WomenView official trial listing → -
Completed NCT NCT00745173
Study Evaluating Premarin and Bazedoxifene Potential Interaction
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-10 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00746096
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
Not yet reported Nobelpharma 115 participants Est. completion 2009-09Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00752635
Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris
Not yet reported Johnson & Johnson Taiwan Ltd 48 participants Est. completion 2005-09Other conditions: Acne VulgarisView official trial listing → -
Terminated NCT NCT00752986
ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial
Not yet reported Genzyme, a Sanofi Company 39 participants Est. completion 2013-09 11 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00754065
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Not yet reported Bayer 409 participants Est. completion 2011-05-10 59 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00755963
Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women
Not yet reported Medical University of Vienna 30 participants Est. completion 2011-07 1 siteOther conditions: Hormone ReplacementView official trial listing → -
Completed NCT NCT00775086
Bioequivalence Study of Patches With Different Equilibration Profiles
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 42 participants Est. completion 2004-08Other conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT00778609
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
Not yet reported Bayer 449 participants Est. completion 2010-12 63 sitesOther conditions: Oral Contraceptive, Headache, Pelvic PainView official trial listing → -
Completed NCT NCT00796133
A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
Not yet reported Population Council 18 participants Est. completion 2014-01 3 sitesOther conditions: OvulationView official trial listing → -
Completed NCT NCT00799708
A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 27 participants Est. completion 2008-10Other conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00803335
The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse
Not yet reported TriHealth Inc. 54 participants Est. completion 2011-05 1 siteOther conditions: Pelvic Organ Prolapse, Vaginal AtrophyView official trial listing → -
Withdrawn NCT NCT00804960
Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?
Not yet reported Center for Human Reproduction Est. completion 2010-04 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00805415
Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens
Not yet reported Bayer 209 participants Est. completion 2004-02 2 sitesOther conditions: Ovulation InhibitionView official trial listing → -
Completed NCT NCT00808132
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
Not yet reported Pfizer 1886 participants Est. completion 2011-02 178 sitesOther conditions: Menopause, OsteoporosisView official trial listing → -
Completed NCT NCT00819312
YAZ, Oral Contraceptive Registration in China
Not yet reported Bayer 675 participants Est. completion 2011-01 17 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00821496
Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects
Not yet reported VIVUS LLC 20 participants Est. completion 2009-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00825617
Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy
Not yet reported University of Aarhus 16 participants Est. completion 2000-06 1 siteOther conditions: Turner SyndromeView official trial listing → -
Withdrawn NCT NCT00826839
Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients
Not yet reported Weill Medical College of Cornell University Est. completion 2012-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00827632
Obesity, Oral Contraception, and Ovarian Suppression
Not yet reported Columbia University 226 participants Est. completion 2008-12 1 siteOther conditions: Ovarian SuppressionView official trial listing → -
Completed NCT NCT00830492
Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
Not yet reported Yazd Research & Clinical Center for Infertility 200 participants Est. completion 2008-12 1 siteOther conditions: Ovarian StimulationView official trial listing → -
Completed NCT NCT00842751
Oral T7 Oral Testosterone in Man
Not yet reported University of Washington 11 participants Est. completion 2009-12 1 siteOther conditions: Healthy Males, Male ContraceptiveView official trial listing → -
Completed NCT NCT00843570
Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment
Not yet reported University of Oxford 159 participants Est. completion 2013-05 2 sitesOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT00844012
Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain
Not yet reported University Magna Graecia 60 participants Est. completion 2010-07 1 siteOther conditions: Endometriosis, Chronic Pelvic PainView official trial listing → -
Completed NCT NCT00848276
Sex Hormones and Blood PCSK9 Levels
Ottawa Hospital Research Institute 61 participants Est. completion 2010-09 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00860964
A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women
Not yet reported Peking Union Medical College 221 participants Est. completion 2006-12Other conditions: OsteoporosisView official trial listing → -
Status unknown NCT NCT00866437
Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel
Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2010-11 1 siteOther conditions: Premenstrual SyndromeView official trial listing → -
Terminated NCT NCT00870220
Initiating Transdermal Estradiol Therapy in Turner's Syndrome
Not yet reported University of Chicago 1 participants Est. completion 2011-03 3 sitesOther conditions: Turner's SyndromeView official trial listing → -
Completed NCT NCT00871858
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer
Not yet reported Institut Bergonié 120 participants Est. completion 2018-07-02 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00877097
Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women
Not yet reported Kuopio University Hospital 167 participants Est. completion 2009-02Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00896571
Transdermal Contraceptive Patch - Endometrial Effects Study
Not yet reported Bayer 92 participants Est. completion 2011-08 1 siteOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT00896636
Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration
Northwestern University 385 participants Est. completion 2022-01 1 siteOther conditions: Breast Cancer, Healthy, no Evidence of DiseaseView official trial listing → -
Suspended NCT NCT00901290
Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects
Not yet reported AstraZeneca 56 participants Est. completion 2009-09 1 siteOther conditions: PharmacokineticsView official trial listing → -
Terminated NCT NCT00903006
Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
Not yet reported, Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2013-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00905684
Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)
Bayer 5446 participants Est. completion 2011-12 13 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00908570
Topical Estriol for Vaginal Health
Not yet reported Gynuity Health Projects 104 participants Est. completion 2011-03 2 sitesOther conditions: Vaginal HealthView official trial listing → -
Completed NCT NCT00914693
EU/LA Pearl Index Study - Transdermal Contraceptive Patch
Not yet reported Bayer 1694 participants Est. completion 2011-09 66 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00915174
Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects
Not yet reported Merz Pharmaceuticals GmbH 36 participants Est. completion 2009-11 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00915915
Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)
Not yet reported Bayer 108 participants Est. completion 2010-04 2 sitesOther conditions: Contraception, Ovulation InhibitionView official trial listing → -
Completed NCT NCT00918476
Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)
Not yet reported Pfizer 14 participants Est. completion 2011-02 1 siteOther conditions: Hepatitis CView official trial listing → -
Status unknown NCT NCT00919919
Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
Not yet reported Rabin Medical Center 60 participants Est. completion 2010-11 1 siteOther conditions: Endometrial Hyperplasia, Endometrial CancerView official trial listing → -
Completed NCT NCT00920985
US Cycle Control and Blood Pressure Study
Not yet reported Bayer 346 participants Est. completion 2010-09 28 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00921115
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Not yet reported University of Kansas Medical Center 42 participants Est. completion 2023-03-20 1 siteOther conditions: Invasive Breast CancerView official trial listing → -
Completed NCT NCT00923572
Yasmin Post Marketing Surveillance
Bayer 777 participants Est. completion 2013-08 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00924560
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
Not yet reported Duramed Research 1361 participants Est. completion 2012-08 46 sitesOther conditions: Bone Mineral DensityView official trial listing → -
Terminated NCT NCT00932152
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
Not yet reported University of Pittsburgh 3 participants Est. completion 2013-01 1 siteOther conditions: Non-small Cell Lung Cancer, Postmenopausal WomenView official trial listing → -
Completed NCT NCT00932321
Study of Safety and Efficacy of an Oral Contraceptive
Not yet reported Warner Chilcott 938 participants Est. completion 2004-11 34 sitesOther conditions: Prevention of PregnancyView official trial listing → -
Completed NCT NCT00941057
Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium
Not yet reported Bayer 43 participants Est. completion 2010-01 1 siteOther conditions: Pharmacology, ClinicalView official trial listing → -
Completed NCT NCT00944918
Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)
Not yet reported AstraZeneca 25 participants Est. completion 2011-06 2 sitesOther conditions: Progression-free SurvivalView official trial listing → -
Completed NCT NCT00946192
Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes
Not yet reported Massachusetts General Hospital 121 participants Est. completion 2021-04 1 siteOther conditions: Exercise-related AmenorrheaView official trial listing → -
Completed NCT NCT00983957
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
Not yet reported Bristol-Myers Squibb 47 participants Est. completion 2010-02 3 sitesOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT00984399
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2024-05-13 5 sitesOther conditions: Atrophic Vaginitis, Breast CancerView official trial listing → -
Completed NCT NCT00984789
Birth Control Patch Study
Not yet reported Bayer 393 participants Est. completion 2010-09 23 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00997893
Research Investigation of Soy and Estrogen
Not yet reported University of Illinois Chicago 96 participants Est. completion 2015-05 1 siteOther conditions: Menopause, Hot FlashesView official trial listing → -
Completed NCT NCT00998257
Regulatory Post Marketing Surveillance Study on YAZ
Bayer 770 participants Est. completion 2011-11 1 siteOther conditions: Contraception, Premenstrual Syndrome, AcneView official trial listing → -
Withdrawn NCT NCT01004419
Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer
Not yet reported University of Wisconsin, Madison Est. completion 2011-05Other conditions: Carcinoma, Non Small Cell LungView official trial listing → -
Terminated NCT NCT01015677
A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)
Not yet reported Merck Sharp & Dohme LLC 99 participants Est. completion 2010-07-30Other conditions: Moderate to Severe Vasomotor Symptoms in Postmenopausal, WomenView official trial listing → -
Completed NCT NCT01040845
A Pharmacokinetic Study of Colchicine With an Oral Contraceptive
Not yet reported Mutual Pharmaceutical Company, Inc. 30 participants Est. completion 2008-02 1 siteOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT01056042
Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain
Not yet reported Prince of Songkla University 112 participants Est. completion 2011-10 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT01063023
Drug Interaction Oral Contraceptive Pill (OCP)
Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2010-06 1 siteOther conditions: Hepatitis C VirusView official trial listing → -
Completed NCT NCT01064453
Angeliq Regulatory Post Marketing Surveillance
Bayer 4078 participants Est. completion 2012-12 1 siteOther conditions: Postmenopausal Period, Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT01065220
Sex Steroids and the Serotonin Transporter
Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 siteOther conditions: TranssexualismView official trial listing → -
Completed NCT NCT01076621
Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months
Novo Nordisk A/S 176 participants Est. completion 2013-06 2 sitesOther conditions: Menopause, Postmenopausal BleedingView official trial listing → -
Terminated NCT NCT01079949
A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
Not yet reported Merck KGaA, Darmstadt, Germany 93 participants Est. completion 2010-10 1 siteOther conditions: Infertility, Ovulation InductionView official trial listing → -
Terminated NCT NCT01083641
Estrogen for Triple Negative Breast Cancer
Not yet reported University of Wisconsin, Madison 17 participants Est. completion 2015-03 1 siteOther conditions: Female Breast CancerView official trial listing → -
Completed NCT NCT01085877
Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
Not yet reported Novo Nordisk A/S 70 participants Est. completion 2010-05 1 siteOther conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Terminated NCT NCT01087593
Estrogens Effect on Pain in Postmenopausal Women Suffering of Fibromyalgia
Not yet reported Ostergotland County Council, Sweden 29 participants Est. completion 2007-10 1 siteOther conditions: FibromyalgiaView official trial listing → -
Completed NCT NCT01088477
Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
University Medical Center Groningen 21 participants Est. completion 2014-02 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01103518
Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
Not yet reported Fundação Educacional Serra dos Órgãos 100 participants Est. completion 2011-01 1 siteOther conditions: Amenorrhea, Dysmenorrhea, Menstruation Disturbances, HyperandrogenismView official trial listing → -
Completed NCT NCT01109979
Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function
Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2016-06 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01112358
Lutropin Alfa in Women at Risk of Poor Response
Not yet reported Merck KGaA, Darmstadt, Germany 58 participants Est. completion 2007-01-30 1 siteOther conditions: Ovarian StimulationView official trial listing → -
Completed NCT NCT01120665
Isolated and Associated Effects of Physical Exercise and Estrogen Therapy on Climactercs Women
Not yet reported University of Sao Paulo General Hospital 62 participants Est. completion 2009-02Other conditions: Women's HealthView official trial listing → -
Completed NCT NCT01129102
Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea
Not yet reported Nobelpharma 215 participants Est. completion 2011-04Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT01137708
CP-690,550 And Oral Contraception Drug-Drug Interaction Study
Not yet reported Pfizer 20 participants Est. completion 2010-07 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01142401
Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Not yet reported National Cancer Institute (NCI) 118 participants Est. completion 2021-01-08 21 sitesOther conditions: Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT01160718
Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy
Not yet reported Swiss Cancer Institute 46 participants Est. completion 2016-09 17 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01174524
Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme
Not yet reported Hospital Geral de Fortaleza 100 participants Est. completion 2008-11 1 siteOther conditions: Quality of Life, Menopause, ContraceptionView official trial listing → -
Status unknown NCT NCT01175759
Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss
Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2011-12 1 siteOther conditions: Abortion, RecurrentView official trial listing → -
Completed NCT NCT01182207
Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 33 participants Est. completion 2006-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01185678
Data on Oral Contraceptives Compliance in Non Stop Regimen
Bayer 8416 participants Est. completion 2010-11 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01185704
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
Not yet reported Merck KGaA, Darmstadt, Germany 136 participants Est. completion 2012-02 1 siteOther conditions: Polycystic Ovarian SyndromeView official trial listing → -
Completed NCT NCT01186796
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
Not yet reported Mayo Clinic 30 participants Est. completion 2013-06 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01195974
A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
Not yet reported ViiV Healthcare 13 participants Est. completion 2011-02-09 1 siteOther conditions: Infection, Human Immunodeficiency Virus, HIV InfectionsView official trial listing → -
Completed NCT NCT01204840
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
Not yet reported Ottawa Fertility Centre 38 participants Est. completion 2015-05 1 siteOther conditions: Infertility, Poor Ovarian ReserveView official trial listing → -
Completed NCT NCT01208324
Estrogen and Serotonin on Changing Brain Chemistry
Not yet reported University of Colorado, Denver 47 participants Est. completion 2018-11 1 siteOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT01210144
EXpression PRofile Endometrium Samples Study
Not yet reported Merck KGaA, Darmstadt, Germany 27 participants Est. completion 2010-08 1 siteOther conditions: In Vitro FertilizationView official trial listing → -
Completed NCT NCT01218386
Pretreatment With Estradiol Valerate
Not yet reported Universitair Ziekenhuis Brussel 80 participants Est. completion 2012-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01219101
The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination
Not yet reported Royan Institute 95 participants Est. completion 2013-02 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01219153
Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET
Not yet reported Cairo University 136 participants Est. completion 2010-12 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01219699
A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Not yet reported Novartis Pharmaceuticals 221 participants Est. completion 2020-04-16 11 sitesOther conditions: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT01232075
Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination
Not yet reported Cairo University 214 participants Est. completion 2010-12 2 sitesOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT01233947
Study of AFP464 +/- Faslodex in ER + Breast Cancer
Not yet reported Tigris Pharmaceuticals 7 participants Est. completion 2012-08 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Completed NCT NCT01236768
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
Not yet reported Agile Therapeutics 407 participants Est. completion 2011-06 21 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01246791
Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers
Not yet reported Nobelpharma 12 participants Est. completion 2011-05Other conditions: HealthyView official trial listing → -
Completed NCT NCT01252186
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Not yet reported Teva Women's Health 265 participants Est. completion 2011-12 24 sitesOther conditions: Hemostasis, Oral ContraceptiveView official trial listing → -
Completed NCT NCT01253187
Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)
Not yet reported Bayer 44 participants Est. completion 2007-09 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01253824
Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
Not yet reported Nobelpharma 14 participants Est. completion 2011-07Other conditions: HealthyView official trial listing → -
Completed NCT NCT01257984
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
Not yet reported Bayer 508 participants Est. completion 2012-09 43 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01258660
Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate
Not yet reported Bayer 172 participants Est. completion 2008-01 1 siteOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT01266213
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women
Not yet reported Samsung Medical Center 147 participants Est. completion 2019-12 1 siteOther conditions: Metastatic Breast Cancer, Estrogen Receptor Positive Tumor, Breast Cancer Nos PremenopausalView official trial listing → -
Completed NCT NCT01277211
A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)
Not yet reported Organon and Co 983 participants Est. completion 2013-09-18Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT01284244
A Randomized Controlled Trial of the Uresta Continence Pessary
Not yet reported Mount Sinai Hospital, Canada 36 participants Est. completion 2014-05 1 siteOther conditions: Stress Urinary IncontinenceView official trial listing → -
Completed NCT NCT01291004
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 206 participants Est. completion 2012-03-31 2 sitesOther conditions: Follicle Development, Ovarian Follicle, Follicle Count, Follicle Size, Oral ContraceptiveView official trial listing → -
Completed NCT NCT01292785
Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity
Medical University of Vienna 80 participants Est. completion 2015-04 1 siteOther conditions: Gender Identity DisorderView official trial listing → -
Completed NCT NCT01293747
Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension
Not yet reported Productos Científicos S. A. de C. V. 30 participants Est. completion 2011-10 1 siteOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT01296555
A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Not yet reported Genentech, Inc. 674 participants Est. completion 2021-06-25 31 sitesOther conditions: Solid Cancers, Non-Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT01297348
Study Of Lybrel In Relation To Venous Thromboembolism
Pfizer 598682 participants Est. completion 2012-04Other conditions: Venous Thrombosis, Pulmonary Embolism, Sinus Thrombosis, IntracranialView official trial listing → -
Completed NCT NCT01300351
Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women
Not yet reported AstraZeneca 249 participants Est. completion 2014-03 15 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01300676
The Effects of Tualang Honey on Postmenopausal Women
Not yet reported, Not yet reported Universiti Sains Malaysia 79 participants Est. completion 2010-06 1 siteOther conditions: Postmenopausal SyndromeView official trial listing → -
Completed NCT NCT01310647
Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders
Not yet reported Instituto de Investigacion Sanitaria La Fe 66 participants Est. completion 2014-02 1 site Stand-aloneOther conditions: Ovarian DiseasesView official trial listing → -
Completed NCT NCT01319968
Postpartum Dyspareunia Resulting From Vaginal Atrophy
Meir Medical Center 117 participants Est. completion 2013-09 2 sitesOther conditions: Vulvovaginal Atrophy, Dyspareunia Among Puerperal WomenView official trial listing → -
Completed NCT NCT01339442
BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer
Not yet reported Washington University School of Medicine 31 participants Est. completion 2016-12-28 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01344031
MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 31 participants 1 siteOther conditions: Estrogen Receptor Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT01344369
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2008-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01345786
Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)
Not yet reported Organon and Co 158 participants Est. completion 2010-06Other conditions: Healthy Postmenopausal FemalesView official trial listing → -
Completed NCT NCT01360996
Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
Not yet reported Woman's 64 participants Est. completion 2015-02 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01361958
Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol
Not yet reported Theramex 38 participants Est. completion 1998-09Other conditions: Suppression of OvulationView official trial listing → -
Completed NCT NCT01367912
Timing of Estrogen Support During the Luteal Phase of in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycle
Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 301 participants Est. completion 2008-11 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01370551
Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients
Not yet reported Medinova AG 16 participants Est. completion 2012-07 2 sitesOther conditions: Atrophic VaginitisView official trial listing → -
Completed NCT NCT01370798
Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications
Not yet reported Hospices Civils de Lyon 244 participants Est. completion 2017-09-18 4 sitesOther conditions: HypospadiasView official trial listing → -
Completed NCT NCT01372293
71A/G HSD17B5 SNP and Effects of Oral Contraceptive Pill in PCOS Women
Not yet reported Federal University of Rio Grande do Sul 49 participants Est. completion 2010-12Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01373931
A Study of LY2216684 in Healthy Females
Not yet reported Eli Lilly and Company 20 participants Est. completion 2011-12 1 siteOther conditions: Depressive Disorder, MajorView official trial listing → -
Status unknown NCT NCT01384331
New Treatments for Troublesome Bleeding in Implanon Users
Not yet reported Family Planning Association New South Wales 200 participants Est. completion 2013-04 1 siteOther conditions: Menstrual ProblemView official trial listing → -
Completed NCT NCT01385280
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
Not yet reported University of Arizona 13 participants Est. completion 2013-10 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01385332
A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors
Not yet reported Parc de Salut Mar 10 participants Est. completion 2012-09 1 siteOther conditions: Stimulation in the OvaryView official trial listing → -
Completed NCT NCT01385618
Gene-polymorphisms Relating to Human Subfertility
Infertility Treatment Center Dortmund 150 participants Est. completion 2015-03 1 siteOther conditions: Estradiol Receptor Polymorphism, Progesterone Receptor Polymorphism, IVF, SubfertilityView official trial listing → -
Completed NCT NCT01394016
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
Not yet reported Eli Lilly and Company 225 participants Est. completion 2022-04-12 3 sitesOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT01418924
Sex Hormones & Serum Sclerostin Level
Bagcilar Training and Research Hospital 45 participants Est. completion 2011-10 1 siteOther conditions: Bony Sclerosis, Testicular; Hormone, CView official trial listing → -
Terminated NCT NCT01428245
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
Not yet reported University of Virginia 3 participants Est. completion 2013-05-14 1 siteOther conditions: Hyperandrogenemia, Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01441947
Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer
Not yet reported Massachusetts General Hospital 68 participants Est. completion 2019-08-09 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01455597
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)
Not yet reported Warner Chilcott 309 participants Est. completion 2012-12-03 64 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Status unknown NCT NCT01459445
Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome
Not yet reported Iuliu Hatieganu University of Medicine and Pharmacy 26 participants Est. completion 2012-01 1 siteOther conditions: Polycystic Ovary Syndrome, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT01465022
Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
Not yet reported University of New Mexico 197 participants Est. completion 2008-06Other conditions: Breast Feeding, ContraceptionView official trial listing → -
Completed NCT NCT01466673
An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment
Not yet reported Janssen-Cilag Ltd.,Thailand 201 participants Est. completion 2010-03 3 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT01475513
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Not yet reported Virginia Commonwealth University 47 participants Est. completion 2014-05-28 1 siteOther conditions: Insulin Sensitivity, Cardiovascular Risk, Perimenopausal DisorderView official trial listing → -
Completed NCT NCT01477632
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
Not yet reported Novo Nordisk A/S 24 participants Est. completion 2005-06 1 siteOther conditions: Menopause, HealthyView official trial listing → -
Completed NCT NCT01480778
Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.
Not yet reported Azidus Brasil 62 participants Est. completion 2015-06 1 siteOther conditions: Irregular PeriodsView official trial listing → -
Completed NCT NCT01482338
Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
Not yet reported Chulalongkorn University 90 participants Est. completion 2012-03 1 siteOther conditions: Premenstrual SyndromeView official trial listing → -
Completed NCT NCT01482416
Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery
Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2014-08 1 siteOther conditions: Unspecified Injury of Brachial Artery, Left Side, Initial EncounterView official trial listing → -
Completed NCT NCT01485419
Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy
University of Pittsburgh 292 participants Est. completion 2012-12 1 siteOther conditions: Traumatic InjuryView official trial listing → -
Completed NCT NCT01486979
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
Not yet reported Novo Nordisk A/S 58 participants Est. completion 2007-05 1 siteOther conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Completed NCT NCT01489852
Estrogen Pretreatment Prior to GnRH Antagonist Protocol
Not yet reported Gemer 472 participants Est. completion 2011-05 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01490190
Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)
Not yet reported Organon and Co 252 participants Est. completion 2012-12-05Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT01498861
Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol
Not yet reported ViiV Healthcare 16 participants Est. completion 2012-03 1 siteOther conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Terminated NCT NCT01500473
Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome
Not yet reported Children's Hospital Los Angeles 1 participants Est. completion 2016-05-11 1 siteOther conditions: Congenital Central Hypoventilation SyndromeView official trial listing → -
Completed NCT NCT01508858
Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
Not yet reported Novo Nordisk A/S 21 participants Est. completion 2007-04 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01509625
Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)
Isabel Blancas 272 participants Est. completion 2014-03 7 sitesOther conditions: Malignant Neoplasm of Breast Stage IVView official trial listing → -
Completed NCT NCT01511822
Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance
Not yet reported AGUNCO Obstetrics and Gynecology Centre 1 siteOther conditions: PCOS, Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01519401
Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.
Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2011-07 1 siteOther conditions: Polycystic Ovary Syndrome, Estro-progestin DrugsView official trial listing → -
Completed NCT NCT01535820
The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2011-07 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01553773
Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
Not yet reported Federal University of São Paulo 30 participants Est. completion 2005-03 1 siteOther conditions: AtrophyView official trial listing → -
Completed NCT NCT01556191
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
Not yet reported Intergroupe Francophone de Cancerologie Thoracique 379 participants Est. completion 2020-06-17 61 sitesOther conditions: Stage IV Lung CancerView official trial listing → -
Completed NCT NCT01560416
Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Not yet reported Dana-Farber Cancer Institute 50 participants Est. completion 2016-06-26 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01569113
Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.
Not yet reported HRA Pharma 76 participants Est. completion 2012-08 3 sitesOther conditions: Emergency ContraceptionView official trial listing → -
Withdrawn NCT NCT01577199
RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders
Not yet reported Weill Medical College of Cornell University Est. completion 2012-12Other conditions: InfertilityView official trial listing → -
Completed NCT NCT01581814
Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome
Not yet reported Catholic University of the Sacred Heart 99 participants Est. completion 2012-03 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01586000
A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women
Not yet reported Kimberly Myer 197 participants Est. completion 2015-05 8 sitesOther conditions: Suppression of OvulationView official trial listing → -
Status unknown NCT NCT01588873
Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome
Not yet reported University of Oulu 42 participants Est. completion 2019-12 1 siteOther conditions: Adverse Effect of Oral Contraceptives, SequelaView official trial listing → -
Status unknown NCT NCT01590849
Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone
Not yet reported Instituto do Coracao 69 participants 1 siteOther conditions: Contraceptive Affecting the Autonomic Nervous System, Contraceptive Affecting Blood PressureView official trial listing → -
Completed NCT NCT01597193
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Not yet reported Pfizer 101 participants Est. completion 2018-01-22 17 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01600274
Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest
Not yet reported Pharbil Waltrop GmbH 20 participants Est. completion 2010-02 1 siteOther conditions: Focus: BioequivalenceView official trial listing → -
Status unknown NCT NCT01603745
Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
Not yet reported Catholic University of the Sacred Heart 10 participants Est. completion 2012-10 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01605071
Timing Estrogen After MenoPaUSe
Not yet reported University of Colorado, Denver 53 participants Est. completion 2017-01 1 siteOther conditions: Insulin ResistanceView official trial listing → -
Status unknown NCT NCT01608698
Comparison of Body Weight Change During Contraception With Belara and Yasmin
Not yet reported Mahidol University 100 participants Est. completion 2016-02 1 siteOther conditions: Body Weight ChangesView official trial listing → -
Completed NCT NCT01615354
A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers
Not yet reported Hoffmann-La Roche 18 participants Est. completion 2013-01 1 siteOther conditions: Healthy VolunteerView official trial listing → -
Terminated NCT NCT01633060
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Not yet reported Novartis Pharmaceuticals 432 participants Est. completion 2017-09-21 197 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01633814
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
Not yet reported University of Missouri-Columbia 4 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: Menopause, Aging, Blood PressureView official trial listing → -
Terminated NCT NCT01634789
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
Not yet reported Pfizer 2 participants Est. completion 2012-11 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01638910
Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects
Not yet reported Bayer 955 participants Est. completion 2014-11 39 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01650168
Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)
Center for Epidemiology and Health Research, Germany 101498 participants Est. completion 2020-12 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01653743
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Not yet reported Merck KGaA, Darmstadt, Germany 81 participants Est. completion 2014-12 6 sitesOther conditions: Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction, Polycystic Ovarian SyndromeView official trial listing → -
Completed NCT NCT01655225
A Study of LY3023414 in Participants With Advanced Cancer
Not yet reported Eli Lilly and Company 156 participants Est. completion 2022-02-02 8 sitesOther conditions: Advanced Cancer, Metastatic Cancer, Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Malignant Mesothelioma, Non-small Cell Lung CancerView official trial listing → -
Status unknown NCT NCT01659008
Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding
Not yet reported Kay I Waud MD PhD 100 participants Est. completion 2016-03 2 sitesOther conditions: Menstrual Cycle and Uterine Bleeding DisordersView official trial listing → -
Status unknown NCT NCT01668056
Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence
Not yet reported University of Sao Paulo General Hospital 30 participants Est. completion 2014-12 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01669291
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
Not yet reported Main Line Fertility Center 43 participants Est. completion 2014-05 1 siteOther conditions: FertilityView official trial listing → -
Completed NCT NCT01670656
A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)
Not yet reported Organon and Co 439 participants Est. completion 2013-09-12Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT01670877
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Not yet reported Washington University School of Medicine 56 participants Est. completion 2021-03-11 17 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT01698164
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Not yet reported Peking Union Medical College Hospital 1200 participants 1 siteCardiovascular disease Other conditions: Menopausal Syndrome, Osteoporosis, Breast CancerView official trial listing → -
Completed NCT NCT01705249
Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women
Not yet reported Novo Nordisk A/S 191 participants Est. completion 2003-06-06 19 sitesOther conditions: Menopause, HealthyView official trial listing → -
Completed NCT NCT01710696
Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome
Not yet reported Novo Nordisk A/S 50 participants Est. completion 2004-07-26 28 sitesOther conditions: Genetic Disorder, Turner SyndromeView official trial listing → -
Completed NCT NCT01746732
A Study of Evacetrapib in Healthy Female Participants
Not yet reported Eli Lilly and Company 23 participants Est. completion 2013-05 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT01768247
HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)
Not yet reported Universitair Ziekenhuis Brussel 15 participants Est. completion 2014-01 1 siteOther conditions: Endometrial Thickness, Pregnancy OutcomeView official trial listing → -
Status unknown NCT NCT01780558
A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FET
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2015-01 1 siteOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT01780610
The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 670 participants Est. completion 2015-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01790282
Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT
Not yet reported Mansoura Integrated Fertility Center 220 participants Est. completion 2015-03 1 siteOther conditions: IVF, InfertilityView official trial listing → -
Completed NCT NCT01797120
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Not yet reported PrECOG, LLC. 131 participants Est. completion 2017-09-12 25 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01798836
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
Not yet reported, Not yet reported National and Kapodistrian University of Athens 17 participants Est. completion 2015-02 1 siteOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT01805817
Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality
Not yet reported Istanbul Training and Research Hospital 1 siteOther conditions: Contraceptive Methods ComparisonView official trial listing → -
Completed NCT NCT01813162
In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Not yet reported CONRAD 101 participants Est. completion 2014-12 2 sitesOther conditions: HIV PreventionView official trial listing → -
Completed NCT NCT01817400
Mediators of Abnormal Reproductive Function in Obesity (MARO)
Not yet reported University of Colorado, Denver 10 participants Est. completion 2014-12 1 siteOther conditions: Infertility, Female, ObesityView official trial listing → -
Completed NCT NCT01817530
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Not yet reported AbbVie 571 participants Est. completion 2015-12Other conditions: Heavy Uterine Bleeding, Uterine FibroidsView official trial listing → -
Completed NCT NCT01822288
The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 siteOther conditions: Menopausal SyndromesView official trial listing → -
Completed NCT NCT01845649
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
Not yet reported Warner Chilcott 550 participants Est. completion 2013-11-20 57 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Status unknown NCT NCT01850095
The Influence of Peripheral Androgen Conversion at Women Adult Acne
Not yet reported Marco Alexandre Dias da Rocha 60 participants Est. completion 2015-01 1 siteOther conditions: Acne, Quality of LifeView official trial listing → -
Terminated NCT NCT01886794
Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse
Not yet reported The University of Texas Medical Branch, Galveston 7 participants Est. completion 2023-12-11 1 siteOther conditions: Pelvic Floor DisordersView official trial listing → -
Withdrawn NCT NCT01895881
Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial
Not yet reported Rush University Medical Center Est. completion 2018-12 1 siteOther conditions: Cerebral Aneurysm, Menopause, TreatmentView official trial listing → -
Completed NCT NCT01896726
A Study of Baricitinib and Birth Control Pills in Healthy Females
Not yet reported Eli Lilly and Company 20 participants Est. completion 2013-10 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01902264
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Not yet reported Bayer 34 participants Est. completion 2015-02 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01903031
Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART
Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84 participants Est. completion 2016-10-10 21 sitesOther conditions: HIV-1 InfectionView official trial listing → -
Completed NCT NCT01909141
Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
Not yet reported Cairo University 100 participants Est. completion 2014-04 1 siteOther conditions: Polycystic Ovary Syndrome, InfertilityView official trial listing → -
Completed NCT NCT01921374
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Not yet reported Monica Levy Andersen 60 participants Est. completion 2014-07 1 siteOther conditions: Other Diseases or ConditionsView official trial listing → -
Status unknown NCT NCT01926210
Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders
Not yet reported Huang Rui 500 participants Est. completion 2016-09 1 siteOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT01928082
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Not yet reported University of Chicago 1 participants Est. completion 2014-08-01 1 site Stand-aloneOther conditions: Hypercalciuria, Hypercalciuria, Familial Idiopathic, Osteopenia, OsteoporosisView official trial listing → -
Completed NCT NCT01933204
Acupuncture for Relieving Perimenopausal Symptoms
Not yet reported, Not yet reported Chengdu University of Traditional Chinese Medicine 220 participants Est. completion 2015-08 2 sitesOther conditions: PerimenopauseView official trial listing → -
Completed NCT NCT01942135
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Not yet reported Pfizer 521 participants Est. completion 2022-09-28 247 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01953211
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
University of Southern California 64 participants 1 siteOther conditions: Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive EfficacyView official trial listing → -
Withdrawn NCT NCT01953809
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
Not yet reported GlaxoSmithKline Est. completion 2015-03Other conditions: Infections, BacterialView official trial listing → -
Completed NCT NCT01958073
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Not yet reported University of California, San Diego 35 participants Est. completion 2017-12 2 sitesOther conditions: Recurrent Urinary Tract InfectionView official trial listing → -
Terminated NCT NCT01963403
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Not yet reported University of California, Davis 26 participants Est. completion 2015-09 2 sitesOther conditions: Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding HeavyView official trial listing → -
Completed NCT NCT01973816
MEdical Versus SUrgical Treatments of Rectal Endometriosis
Not yet reported University Hospital, Rouen 78 participants Est. completion 2022-10-11 11 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT01980680
The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients
Not yet reported Peter Humaidan 50 participants Est. completion 2020-05 1 siteOther conditions: InfertilityView official trial listing → -
Active, not recruiting NCT NCT01984138
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
Not yet reported Polly A. Niravath, MD 33 participants Est. completion 2026-06 1 siteOther conditions: Estrogen Receptor Positive Breast Cancer, Breast CancerView official trial listing → -
Completed NCT NCT01984320
Cabergoline and Coasting to Prevent OHSS
Not yet reported Cairo University 300 participants Est. completion 2015-07 1 siteOther conditions: OHSSView official trial listing → -
Withdrawn NCT NCT01986764
E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy
Not yet reported University of Pennsylvania Est. completion 2013-07-01 1 siteOther conditions: Planned RRSOView official trial listing → -
Completed NCT NCT01989780
Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer
Not yet reported Japan Breast Cancer Research Group 160 participants Est. completion 2019-06 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT02000193
Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer
Not yet reported Sun Yat-sen University 58 participants Est. completion 2018-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02021097
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Not yet reported Regenex Pharmaceutical, China 1008 participants Est. completion 2016-02 21 sitesOther conditions: Oral ContraceptiveView official trial listing → -
Completed NCT NCT02026973
Impact of Endogenous E2 on SSI and GH Rebound
Not yet reported Mayo Clinic 62 participants Est. completion 2015-11 1 siteOther conditions: Normal Healthy VolunteersView official trial listing → -
Completed NCT NCT02028507
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
Not yet reported Spanish Breast Cancer Research Group 693 participants Est. completion 2021-01-11 37 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02036879
Gender Disparity and Hormones in Cystic Fibrosis
Not yet reported University of Texas Southwestern Medical Center 55 participants Est. completion 2018-08 2 sitesOther conditions: Cystic Fibrosis (CF)View official trial listing → -
Completed NCT NCT02038335
HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC
University of Pittsburgh 451 participants Est. completion 2020-12 1 siteObstructive sleep apnea Other conditions: Contraception, HIV, MicrobiotaView official trial listing → -
Completed NCT NCT02042196
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
Not yet reported University of Colorado, Denver 100 participants Est. completion 2016-05-02 1 site Stand-aloneOther conditions: Menopause, AgingView official trial listing → -
Completed NCT NCT02049957
Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer
Not yet reported Calithera Biosciences, Inc 118 participants Est. completion 2018-06-29 40 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02057133
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Not yet reported Eli Lilly and Company 198 participants Est. completion 2026-12 13 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT02072512
The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer
Not yet reported Hospital Affiliated to Military Medical Science, Beijing 180 participants Est. completion 2016-12 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02086032
The Effect of Different Types of Progestin on Sleeping of Menopausal Women
Not yet reported Chiang Mai University 100 participants Est. completion 2015-07 1 siteOther conditions: Menopausal and Postmenopausal DisordersView official trial listing → -
Status unknown NCT NCT02086318
A New Algorithm to Predict Ovarian Age
University Magna Graecia 720 participants Est. completion 2018-06 1 siteOther conditions: Infertility, Polycystic Ovary Syndrome, Premature Ovarian Failure (POF), Ovarian Cysts, EndometriosisView official trial listing → -
Completed NCT NCT02088684
Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 70 participants Est. completion 2018-04-17 11 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02089620
Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
Not yet reported Beni-Suef University 210 participants Est. completion 2015-06 1 siteOther conditions: Premenstrual SyndromeView official trial listing → -
Completed NCT NCT02103569
Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325
Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2014-07Other conditions: Hepatitis CView official trial listing → -
Status unknown NCT NCT02114645
The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes
Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 100 participants Est. completion 2015-04 1 siteOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT02115594
Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer
Not yet reported Syndax Pharmaceuticals Est. completion 2016-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02116803
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective
Not yet reported, Not yet reported Novartis Pharmaceuticals 12 participants Est. completion 2016-11-28 9 sitesOther conditions: Solid TumorsView official trial listing → -
Completed NCT NCT02122198
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Not yet reported University of Colorado, Denver 17 participants Est. completion 2017-09-15 2 sitesCardiovascular disease Other conditions: Cognitive Impairment, Executive Dysfunction, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT02127593
A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities
Not yet reported Janssen Research & Development, LLC 101 participants Est. completion 2014-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02137083
A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer
Not yet reported Fudan University 22 participants Est. completion 2017-07 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT02140437
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC
Not yet reported Fudan University Est. completion 2016-06Other conditions: Carcinoma Breast Stage IVView official trial listing → -
Terminated NCT NCT02144246
Contraceptive Hormones and Women With Cystic Fibrosis
Not yet reported University of Pennsylvania 5 participants 1 siteOther conditions: Cystic Fibrosis Exacerbations While on and Off Hormonal ContraceptionView official trial listing → -
Completed NCT NCT02148393
Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
Not yet reported Universitair Ziekenhuis Brussel 212 participants Est. completion 2017-02-28 1 siteOther conditions: Infertility, OHSSView official trial listing → -
Completed NCT NCT02157467
Study of Combined Oral Contraceptive Effects in Female Subjects
Not yet reported ViiV Healthcare 46 participants Est. completion 2014-08-25Other conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT02159131
Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects
Not yet reported ViiV Healthcare 20 participants Est. completion 2014-12 1 siteOther conditions: Infections, Human Immunodeficiency Virus and HepatitisView official trial listing → -
Completed NCT NCT02159326
Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women
Not yet reported Bayer 31 participants Est. completion 2015-07 1 siteOther conditions: Drug InteractionsView official trial listing → -
Completed NCT NCT02161614
Vascular Effect of Estradiol Valerate Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery
Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2015-12 1 siteOther conditions: Flow-mediated Dilation Evaluation of the Brachial ArteryView official trial listing → -
Completed NCT NCT02170038
Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol
Not yet reported Bayer 16 participants Est. completion 2015-03 1 siteOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT02182791
Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women
Not yet reported Boehringer Ingelheim 14 participantsOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT02184364
Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints
Not yet reported Boehringer Ingelheim 161 participantsOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT02186782
Concomitant CC and E2 Versus CC Alone in Ovulation Induction
Not yet reported Maher elesawi kamel elesawi 600 participants Est. completion 2018-08 3 sitesOther conditions: Infertility, AnovulationView official trial listing → -
Completed NCT NCT02197208
A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET
Not yet reported The University of Hong Kong 300 participants Est. completion 2015-12 2 sitesOther conditions: Subfertility, PregnancyView official trial listing → -
Completed NCT NCT02200952
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
San Carlo Public Hospital, Potenza, Italy 16 participants Est. completion 2014-06-30 1 siteOther conditions: Ovarian Hyperstimulation SyndromeView official trial listing → -
Completed NCT NCT02206984
Endocrine Response in Women With Invasive Lobular Breast Cancer
Not yet reported Priscilla McAuliffe 201 participants Est. completion 2024-07-19 12 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02210702
Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales
Not yet reported The Jones Institute 33 participants 1 siteOther conditions: Postpartum Depressive Mood, Postpartum Sexual FunctionView official trial listing → -
Completed NCT NCT02215395
An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Women
Not yet reported Population Council 45 participants Est. completion 2015-04 1 siteOther conditions: Antifungal Drug Adverse ReactionView official trial listing → -
Completed NCT NCT02216786
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer
Not yet reported Queen Mary University of London 333 participants Est. completion 2021-12-31 79 sitesOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02225080
Duragen® Secure Post Marketing Clinical Follow-up (PMCF)
Integra LifeSciences Corporation 100 participants Est. completion 2016-06 5 sitesOther conditions: Dura Mater Nick Cut or Tear, SurgeryView official trial listing → -
Terminated NCT NCT02233621
Assessment of Performance of [18F]-FES for Endometriosis Diagnosis
Not yet reported University Hospital, Angers 31 participants Est. completion 2016-04-06 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT02237079
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
Not yet reported Tulane University Health Sciences Center 17 participants Est. completion 2018-04 1 siteOther conditions: Obesity, Glucose Homeostasis, Postmenopausal SymptomsView official trial listing → -
Status unknown NCT NCT02237131
Continuous Versus Cyclic Oral Contraceptives for Endometriosis
Not yet reported University of Athens 50 participants Est. completion 2015-12 1 siteOther conditions: Dysmenorrhea, Pelvic Pain, Dyspareunia, EndometriomaView official trial listing → -
Active, not recruiting NCT NCT02238808
A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers
Not yet reported AHS Cancer Control Alberta 19 participants Est. completion 2028-06 1 siteOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Terminated NCT NCT02245438
Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers
Not yet reported Boehringer Ingelheim 52 participantsOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02251925
Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles
Not yet reported Royan Institute 460 participants Est. completion 2015-11 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02253173
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
Not yet reported TherapeuticsMD 764 participants Est. completion 2015-10 105 sitesOther conditions: Vulvovaginal Atrophy, Menopause, Dyspareunia, Painful IntercourseView official trial listing → -
Completed NCT NCT02255175
Perimenopausal Effects of Estradiol on Reward Responsiveness
Not yet reported University of North Carolina, Chapel Hill 64 participants Est. completion 2018-10-17 1 site Stand-aloneOther conditions: Perimenopausal DepressionView official trial listing → -
Status unknown NCT NCT02257671
Oral Contraceptives and Economic Behaviour
Not yet reported Karolinska University Hospital 400 participants Est. completion 2015-12 1 siteOther conditions: Female ContraceptionView official trial listing → -
Status unknown NCT NCT02264743
Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2015-11 3 sitesOther conditions: Venous Thrombosis, Insulin ResistanceView official trial listing → -
Completed NCT NCT02272647
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women
Not yet reported Mayo Clinic 47 participants Est. completion 2018-02 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02273791
HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
Mansoura University 126 participants Est. completion 2016-04 2 sitesOther conditions: Infertility, Polycystic Ovarian SyndromeView official trial listing → -
Withdrawn NCT NCT02292732
A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors
Not yet reported GlaxoSmithKline Est. completion 2017-05Other conditions: CancerView official trial listing → -
Completed NCT NCT02308904
Reproductive Capacity and Iron Burden in Thalassemia
Not yet reported UCSF Benioff Children's Hospital Oakland 59 participants Est. completion 2020-09-01 1 siteOther conditions: THALASSEMIA MAJORView official trial listing → -
Completed NCT NCT02313415
Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 26 participants Est. completion 2017-08-31 1 siteOther conditions: Infertility, Intrauterine AdhesionsView official trial listing → -
Withdrawn NCT NCT02316249
Vaginal Creams to Reduce Vaginal Erosion in Pessary Users
Not yet reported Northwell Health Est. completion 2015-08 1 siteOther conditions: Atrophy of Vagina, Vaginal Ulceration, VaginitisView official trial listing → -
Status unknown NCT NCT02330757
HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients
Not yet reported Mansoura University 150 participants Est. completion 2024-12-31 2 sitesOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02333253
Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase
Not yet reported Cairo University 60 participants Est. completion 2016-01 1 siteOther conditions: Other Complications Associated With Artificial FertilizationView official trial listing → -
Status unknown NCT NCT02344472
Detect V / CHEVENDO (Chemo vs. Endo)
Not yet reported Prof. Wolfgang Janni 271 participants Est. completion 2025-01-31 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT02345772
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
Not yet reported, Not yet reported Western Regional Medical Center 4 participants Est. completion 2015-11 1 siteOther conditions: HER2-positive Breast Cancer, ER-positive Breast CancerView official trial listing → -
Completed NCT NCT02349399
Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases
Bayer 26065 participants Est. completion 2016-03-01 3 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT02352597
Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS
Not yet reported Cairo University 150 participants Est. completion 2015-01Other conditions: Polycystic OvariesView official trial listing → -
Completed NCT NCT02362711
Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea
Not yet reported Nobelpharma 248 participants Est. completion 2017-01-28Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT02384239
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Not yet reported University of California, San Francisco 70 participants Est. completion 2021-01-31 9 sitesOther conditions: Metastatic Breast Cancer, Hormone Receptor PositiveView official trial listing → -
Status unknown NCT NCT02385448
Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery
Not yet reported The University of Hong Kong 144 participants Est. completion 2019-02 1 siteOther conditions: EndometriosisView official trial listing → -
Status unknown NCT NCT02393482
Psychological Impact of Amenorrhea in Women With Endometriosis
Not yet reported University of Cagliari 50 participants Est. completion 2022-06 1 siteOther conditions: Amenorrhea, Endometriosis, Quality of LifeView official trial listing → -
Status unknown NCT NCT02394496
Overcoming Endocrine Resistance in Metastatic Breast Cancer
Not yet reported Consorzio Oncotech 396 participants Est. completion 2017-01 69 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT02404051
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
Not yet reported Consorzio Oncotech 745 participants Est. completion 2019-01 41 sitesOther conditions: Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Locally Advanced Malignant NeoplasmView official trial listing → -
Completed NCT NCT02406690
Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects
Reproductive Medicine Associates of New Jersey 1 participants Est. completion 2015-09-17 1 siteOther conditions: Endometrial DysfunctionView official trial listing → -
Completed NCT NCT02410031
Risk Minimisation Study for Diane-35 and Its Generics
Bayer 759 participants Est. completion 2016-03-04 5 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT02413008
A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Not yet reported ITF Research Pharma, S.L.U. 61 participants Est. completion 2017-02-10 6 sitesOther conditions: Vaginal AtrophyView official trial listing → -
Completed NCT NCT02419729
Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy
Not yet reported Faculdade de Medicina do ABC 45 participants Est. completion 2015-11 1 siteOther conditions: Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT02447328
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Not yet reported AstraZeneca 83 participants Est. completion 2020-09-16 9 sitesOther conditions: Locally Advanced or, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02449902
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
Not yet reported TherapeuticsMD 50 participants Est. completion 2013-09 1 siteOther conditions: Menopause, Vulvovaginal Atrophy, Painful Intercourse, DyspareuniaView official trial listing → -
Completed NCT NCT02451228
Indomethacin PK and PD Therapy in Pregnancy
The University of Texas Medical Branch, Galveston 62 participants Est. completion 2018-12-31 6 sitesOther conditions: Premature Labor, Pregnancy, Premature BirthView official trial listing → -
Completed NCT NCT02455453
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Not yet reported Washington University School of Medicine 47 participants Est. completion 2019-01-03 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02461875
Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome
Not yet reported Aljazeera Hospital 236 participants Est. completion 2015-12 1 siteOther conditions: OHSSView official trial listing → -
Completed NCT NCT02475265
Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa
Not yet reported Massachusetts General Hospital 11 participants Est. completion 2018-07-30 1 siteObstructive sleep apnea Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT02480881
A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)
Not yet reported ViiV Healthcare 26 participants Est. completion 2016-01-11 2 sitesOther conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Status unknown NCT NCT02480985
The PIT-TBI Pilot Study
Not yet reported CHU de Quebec-Universite Laval 70 participants Est. completion 2018-03 5 sitesOther conditions: Pituitary Disorders, Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT02486757
Investigation of Female Reproductive Hormone Dynamics During Adolescence
Not yet reported Massachusetts General Hospital 9 participants Est. completion 2016-03-01 1 site Stand-aloneOther conditions: Menstruation DisturbancesView official trial listing → -
Completed NCT NCT02494297
DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Center for Epidemiology and Health Research, Germany 1597 participants Est. completion 2016-10-31 1 siteOther conditions: Hirsutism, Androgenetic Alopecia, Severe Anemia, Seborrhea, PCOSView official trial listing → -
Status unknown NCT NCT02494609
Oral Contraceptive DDI Study
Not yet reported Lexicon Pharmaceuticals 30 participants 2 sitesOther conditions: HealthyView official trial listing → -
Terminated NCT NCT02494713
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-09-14 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT02496052
The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions
Not yet reported Beijing Obstetrics and Gynecology Hospital 300 participants Est. completion 2017-06 1 siteOther conditions: Intrauterine AdhesionsView official trial listing → -
No Longer Available NCT NCT02510079
Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.
W. Dalton Dietrich 1 siteOther conditions: Sciatic Nerve InjuryView official trial listing → -
Completed NCT NCT02516202
The Vaginal Health Trial
Not yet reported Fred Hutchinson Cancer Center 302 participants Est. completion 2017-07 2 sitesOther conditions: Atrophy of Vagina, Menopause, Dyspareunia (Female)View official trial listing → -
Completed NCT NCT02524561
KEEPS Mammographic Density And Breast Health Ancillary Study
Not yet reported Brigham and Women's Hospital 517 participants Est. completion 2013-12 1 siteOther conditions: Mammographic Density, Abnormal MammogramView official trial listing → -
Completed NCT NCT02524769
The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides
Not yet reported Loyola University 27 participants Est. completion 2017-06 1 siteOther conditions: Overactive BladderView official trial listing → -
Status unknown NCT NCT02525276
Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause
Not yet reported Copenhagen University Hospital, Rigshospitalet 48 participants Est. completion 2018-08Metabolic syndromeView official trial listing → -
Completed NCT NCT02528383
Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors
Not yet reported Susan Tannenbaum 3 participants Est. completion 2017-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02529683
Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya
Not yet reported Centers for Disease Control and Prevention 200 participants Est. completion 2015-08Other conditions: Hormonal ContraceptionView official trial listing → -
Completed NCT NCT02533427
Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol
Not yet reported Gilead Sciences 15 participants Est. completion 2016-03-18 1 siteOther conditions: HCV InfectionView official trial listing → -
Completed NCT NCT02549430
To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy
Not yet reported Fondazione Sandro Pitigliani 115 participants Est. completion 2017-02-09 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02550977
Russia/Ukraine Suppression of Ovarian Activity Study
Not yet reported Bayer 91 participants Est. completion 2016-08-15 8 sitesOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT02577913
European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception
Center for Epidemiology and Health Research, Germany 2281 participants Est. completion 2019-05-22 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT02599714
Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer
Not yet reported AstraZeneca 54 participants Est. completion 2023-11-23 7 sitesOther conditions: Advanced and Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT02617108
Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Fu Xing Hospital, Capital Medical University 310 participants Est. completion 2021-11Other conditions: Uterine SeptumView official trial listing → -
Completed NCT NCT02618148
Hormone Estradiol Replacement Therapy Additional Herbals
Not yet reported Trieu, Nguyen Thi, M.D. 60 participants Est. completion 2015-06 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02636972
The Progression From Dysmenorrhoea to Chronic Pelvic Pain
University of Adelaide 56 participants Est. completion 2016-01 1 siteOther conditions: Dysmenorrhoea, Pelvic Pain, Chronic PainView official trial listing → -
Status unknown NCT NCT02638922
Evaluation and Treatment of Tall Statured Girls
Copenhagen University Hospital, Rigshospitalet 304 participants Est. completion 2017-12Other conditions: Constitutional Tall StatureView official trial listing → -
Completed NCT NCT02640755
Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase
Not yet reported AstraZeneca 4 participants Est. completion 2017-07-06 1 siteOther conditions: Solid MalignanciesView official trial listing → -
Status unknown NCT NCT02646735
Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients
Not yet reported Chinese Academy of Medical Sciences 148 participants Est. completion 2020-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02655146
the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .
Not yet reported Chong Qing Reproducive and Genetic Institute 700 participants Est. completion 2017-03 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02657343
An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
Not yet reported, Not yet reported Dana-Farber Cancer Institute 25 participants Est. completion 2022-06-30 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02660294
Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI
Not yet reported, Not yet reported Ain Shams University 30 participants Est. completion 2017-04 1 siteOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT02668822
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Not yet reported Organon and Co 18 participants Est. completion 2016-09-12Other conditions: DysmenorrheaView official trial listing → -
Terminated NCT NCT02669238
Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis
Not yet reported, Not yet reported Centre Hospitalier Universitaire de la Réunion 2 participants Est. completion 2019-10-10 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT02670785
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
Not yet reported Warner Chilcott 203 participants Est. completion 2016-11-14 20 sitesOther conditions: Vulvovaginal Atrophy, Menopause, DyspareuniaView official trial listing → -
Completed NCT NCT02673606
Impact of Estrogen on Fear Extinction R61
Not yet reported NYU Langone Health 136 participants Est. completion 2019-04-15 1 siteOther conditions: Fear, Fear; Examination, PhobicView official trial listing → -
Completed NCT NCT02675231
A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
Not yet reported Eli Lilly and Company 237 participants Est. completion 2023-11-09 93 sitesOther conditions: Hormone Receptor Positive Breast Cancer, HER-2 Positive Breast CancerView official trial listing → -
Status unknown NCT NCT02677259
Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles
Not yet reported One Fertility 506 participants Est. completion 2018-06Other conditions: IVFView official trial listing → -
Status unknown NCT NCT02681536
Miniflare Versus Long Protocol in Poor Responders
Not yet reported Woman's Health University Hospital, Egypt 200 participants Est. completion 2016-09 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02689843
Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
Not yet reported Shiraz University of Medical Sciences 90 participants Est. completion 2018-12-30 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Status unknown NCT NCT02690480
Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer
Not yet reported Spanish Breast Cancer Research Group 189 participants Est. completion 2023-12 32 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02691936
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
Not yet reported The Cleveland Clinic 69 participants Est. completion 2018-12 6 sitesOther conditions: Atrophic Vaginitis, MenopauseView official trial listing → -
Terminated NCT NCT02693002
Estrogen Diastolic Heart Failure
Not yet reported Gretchen Wells 4 participants Est. completion 2016-11 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02694809
The PROMISE Study: Duavee in Women With DCIS
Not yet reported Northwestern University 142 participants Est. completion 2024-06-19 10 sitesOther conditions: Ductal Breast Carcinoma In Situ, PostmenopausalView official trial listing → -
Terminated NCT NCT02701452
Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
Not yet reported University Hospital, Lille 1 participants Est. completion 2019-01-01Other conditions: Ovarian Hyperstimulation Syndrome, HypercoagulabilityView official trial listing → -
Completed NCT NCT02705963
A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors
Not yet reported Novartis Pharmaceuticals 19 participants Est. completion 2019-08-29 7 sitesOther conditions: Solid TumorsView official trial listing → -
Status unknown NCT NCT02715232
Effects of Sex Steroids on the Serotonin System
Not yet reported Medical University of Vienna 92 participants Est. completion 2020-12 1 siteOther conditions: Gender DysphoriaView official trial listing → -
Completed NCT NCT02718378
Evaluation of Safety and Efficacy of Estetrol in Healthy Men
Not yet reported Pantarhei Oncology B.V. 45 participants Est. completion 2017-02 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT02720224
Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol
Not yet reported Estetra 6 participants Est. completion 2016-04 1 siteOther conditions: Contraception, MenopauseView official trial listing → -
Completed NCT NCT02726971
Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion
Not yet reported, Not yet reported Fu Xing Hospital, Capital Medical University 141 participants Est. completion 2016-08 1 siteOther conditions: Asherman SyndromeView official trial listing → -
Completed NCT NCT02729545
The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome
Not yet reported Beijing Hospital of Integrated Traditional Chinese and Western Medicine 60 participants Est. completion 2018-05 1 siteOther conditions: Polycystic Ovarian SyndromeView official trial listing → -
Status unknown NCT NCT02733731
The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis
Not yet reported First Affiliated Hospital, Sun Yat-Sen University 80 participants Est. completion 2016-06 1 siteOther conditions: Atrophic VaginitisView official trial listing → -
Completed NCT NCT02736032
Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist
Not yet reported Cairo University 310 participants Est. completion 2018-05 3 sitesOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02737800
Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients
Not yet reported Kasr El Aini Hospital 88 participants Est. completion 2017-08 1 siteOther conditions: EndometriomaView official trial listing → -
Status unknown NCT NCT02744131
OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women
Not yet reported Kar Clinic & Hospital Pvt. Ltd. 100 participants Est. completion 2019-12 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT02751385
Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer
Not yet reported Boehringer Ingelheim 2 participants Est. completion 2017-11-28 1 siteOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Status unknown NCT NCT02752568
Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure
Not yet reported Kasr El Aini Hospital 300 participants Est. completion 2016-12Other conditions: Recurrent Implantation FailureView official trial listing → -
Status unknown NCT NCT02755038
Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)
Bnai Zion Medical Center 40 participants Est. completion 2017-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02756364
Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy
Not yet reported Calithera Biosciences, Inc 141 participants Est. completion 2019-11-25 53 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Withdrawn NCT NCT02757287
Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors
Not yet reported Fundacion Dexeus Est. completion 2018-12-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
Not yet reported Ohio State University Comprehensive Cancer Center 14 participants Est. completion 2025-08-31 3 sitesOther conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02763566
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Not yet reported Eli Lilly and Company 463 participants Est. completion 2028-03 45 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02770365
Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
Not yet reported Padagis LLC 695 participants Est. completion 2016-11 1 siteOther conditions: AtrophyView official trial listing → -
Active, not recruiting NCT NCT02778685
Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer
Not yet reported City of Hope Medical Center 47 participants Est. completion 2026-03-30 7 sitesOther conditions: Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Terminated NCT NCT02780791
Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary
Not yet reported Insel Gruppe AG, University Hospital Bern 1 participants Est. completion 2020-07-31 1 siteOther conditions: Infertility, Ovarian Failure, PrematureView official trial listing → -
Withdrawn NCT NCT02792153
Estradiol and Fear Extinction in Anorexia Nervosa (AN)
Not yet reported Johns Hopkins University Est. completion 2018-08-22 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT02795039
Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects
Not yet reported Fresenius Kabi 266 participants Est. completion 2017-03-03 3 sitesOther conditions: HealthyView official trial listing → -
Completed NCT NCT02817828
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study
Not yet reported Estetra 1577 participants Est. completion 2018-04-26 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT02828852
Study of the Platelet Function During the Last Month of Pregnancy
Not yet reported University Hospital, Toulouse 60 participants Est. completion 2016-07 1 siteOther conditions: PregnancyView official trial listing → -
Completed NCT NCT02834312
E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)
Not yet reported Donesta Bioscience 260 participants Est. completion 2018-01-22 1 siteOther conditions: Hot FlushesView official trial listing → -
Status unknown NCT NCT02838576
Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women
Not yet reported Hospital de Clinicas de Porto Alegre 72 participants Est. completion 2020-12-31 1 siteOther conditions: ArthralgiaView official trial listing → -
Completed NCT NCT02845219
A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
Not yet reported Novo Nordisk A/S 25 participants Est. completion 2016-12 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT02845388
Sildenafil Citrate in Frozen Embryo Transfer
Not yet reported Omar Ahmed El Sayed Saad 90 participants Est. completion 2016-06Other conditions: InfertilityView official trial listing → -
Completed NCT NCT02846142
Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers
Not yet reported Proteostasis Therapeutics, Inc. 94 participants Est. completion 2017-03 1 siteOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT02847806
Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man
Not yet reported University Hospital, Caen 6 participants Est. completion 2016-08 1 siteOther conditions: HypogonadismView official trial listing → -
Completed NCT NCT02855294
The Effect of Oral Contraceptives on Women Balance
Not yet reported Cairo University 100 participants Est. completion 2016-07 1 siteOther conditions: Joint StabiliotyView official trial listing → -
Completed NCT NCT02859285
A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women
Not yet reported ProHealth Care, Inc 30 participants Est. completion 2020-03-10 1 siteOther conditions: Hypoactive Sexual Desire DisorderView official trial listing → -
Completed NCT NCT02866786
The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS
Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2017-08-01 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT02866955
Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.
Not yet reported Institut de Cancérologie de Lorraine 100 participants Est. completion 2015-08-28 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02872818
Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Not yet reported Kayseri Education and Research Hospital 40 participants Est. completion 2015-03 1 siteOther conditions: Apoptotic Signal Pathways in Endometrial HyperplasiaView official trial listing → -
Completed NCT NCT02894398
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sitesOther conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Status unknown NCT NCT02909361
Fulvestrant 500mg in Patients With Advanced Breast Cancer
Fudan University 500 participants Est. completion 2022-10 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02911844
Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
Not yet reported University of Pennsylvania 5 participants Est. completion 2018-12-05 1 siteOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Completed NCT NCT02913430
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
Not yet reported Shannon Puhalla 7 participants Est. completion 2024-04-30 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT02922348
Hormone Replacement for Premature Ovarian Insufficiency
Not yet reported University of Pennsylvania Est. completion 2018-12-01 1 site Stand-aloneOther conditions: Primary Ovarian InsufficiencyView official trial listing → -
Terminated NCT NCT02936206
Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.
Not yet reported Icahn School of Medicine at Mount Sinai 2 participants Est. completion 2020-05-01 3 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02955394
Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Not yet reported University of Colorado, Denver 61 participants Est. completion 2027-02 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02957630
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
Not yet reported, Not yet reported Estetra 101 participants Est. completion 2017-10-09 1 siteOther conditions: Contraception, Liver Metabolism, Hemostasis ParameterView official trial listing → -
Completed NCT NCT02958852
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer
Not yet reported Lund University Hospital 126 participants Est. completion 2025-01-15 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02967510
Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy
Not yet reported ITF Research Pharma, S.L.U. 283 participants Est. completion 2018-05 23 sitesOther conditions: Vaginal AtrophyView official trial listing → -
Status unknown NCT NCT02983071
G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported G1 Therapeutics, Inc. 102 participants Est. completion 2023-10 8 sitesOther conditions: Carcinoma, Ductal, Breast, Breast Cancer, Breast NeoplasmView official trial listing → -
Terminated NCT NCT02983604
GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
Not yet reported, Not yet reported Gilead Sciences 14 participants Est. completion 2018-07-19 6 sitesOther conditions: Advanced Estrogen Receptor Positive HER2- Breast CancerView official trial listing → -
Status unknown NCT NCT02984696
Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea
Not yet reported Catholic University of the Sacred Heart 20 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: Hypothalamic AmenorrheaView official trial listing → -
Terminated NCT NCT03003949
The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood
Not yet reported University of North Carolina, Chapel Hill 82 participants Est. completion 2020-05-10 2 sitesOther conditions: Perimenopausal Disorder, Stress, EmotionalView official trial listing → -
Completed NCT NCT03007979
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
Not yet reported Washington University School of Medicine 55 participants Est. completion 2023-03-31 2 sitesOther conditions: Breast Cancer, Breast Carcinoma, Cancer of Breast, Malignant Tumor of BreastView official trial listing → -
Completed NCT NCT03018366
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
Not yet reported Cedars-Sinai Medical Center 29 participants Est. completion 2023-02-01 1 siteCardiovascular disease Other conditions: Estrogen Deficiency, Functional Hypothalamic Amenorrhea, Endothelial DysfunctionView official trial listing → -
Status unknown NCT NCT03024580
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer
Not yet reported Instituto Nacional de Cancer, Brazil 20 participants Est. completion 2020-09 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Status unknown NCT NCT03033160
Vaginal Estrogen for Asymptomatic Microscopic Hematuria
Not yet reported Boston Urogynecology Associates 68 participants Est. completion 2020-12-30 1 siteOther conditions: Asymptomatic Microscopic HematuriaView official trial listing → -
Completed NCT NCT03041129
Post-Prandial Liver Glucose Metabolism in PCOS
University of Colorado, Denver 19 participants Est. completion 2018-09-29 1 siteOther conditions: Polycystic Ovarian Syndrome, Obesity, Hepatic SteatosisView official trial listing → -
Completed NCT NCT03043924
Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
Not yet reported University Hospital, Lille 52 participants Est. completion 2022-04-15 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT03047330
Menopausal Sleep Fragmentation and Body Fat Gain
Not yet reported Brigham and Women's Hospital 41 participants Est. completion 2022-08-01 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT03056755
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
Not yet reported Novartis Pharmaceuticals 383 participants Est. completion 2024-11-12 94 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03060304
The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.
Not yet reported Sun Yat-sen University 100 participants Est. completion 2020-06Other conditions: EndometriumView official trial listing → -
Completed NCT NCT03075956
Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers
Not yet reported Estetra 31 participants Est. completion 2017-08-02 1 siteOther conditions: Contraception, MenopauseView official trial listing → -
Status unknown NCT NCT03081130
Intravenous Laser Irradiation Effect on Treatment Resistant Thin Endometrium
Kaohsiung Veterans General Hospital. 60 participants Est. completion 2018-03-31 1 siteOther conditions: Endometrium, LaserView official trial listing → -
Completed NCT NCT03103087
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Not yet reported Myovant Sciences GmbH 382 participants Est. completion 2020-09-16 127 sitesOther conditions: Heavy Menstrual Bleeding, Uterine FibroidView official trial listing → -
Completed NCT NCT03106454
Ovulation Incidence in Oral Contraceptive Users
Not yet reported University of Southern California 58 participants Est. completion 2024-01-01 1 siteOther conditions: Contraception, OvulationView official trial listing → -
Completed NCT NCT03111511
A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)
Not yet reported Janssen Sciences Ireland UC 18 participants Est. completion 2017-08-23 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03112226
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
Not yet reported University of Colorado, Denver 19 participants Est. completion 2020-06-21 2 sitesOther conditions: Cognitive Impairment, Estrogen Deficiency, Menopause, Endothelial Dysfunction, Vascular StiffnessView official trial listing → -
Status unknown NCT NCT03120728
Application for the Etonogestrel/Ethinyl Estradiol Ring
Not yet reported University of Southern California 36 participants Est. completion 2018-07-01 2 sitesOther conditions: Emergency Contraception, Healthy, Reproductive Age WomenView official trial listing → -
Completed NCT NCT03124524
Treatment Choice in Primary Dysmenorrhea
Not yet reported Adana Numune Training and Research Hospital 99 participants Est. completion 2016-10-10Other conditions: Primary DysmenorrheaView official trial listing → -
Terminated NCT NCT03134638
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Not yet reported Syros Pharmaceuticals 107 participants Est. completion 2020-06-24 20 sitesOther conditions: Advanced Solid Tumors, Ovarian Cancer, Breast CancerView official trial listing → -
Withdrawn NCT NCT03169777
QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28Other conditions: Colorectal CancerView official trial listing → -
Terminated NCT NCT03172533
Estrogen Replacement in Anorexia Nervosa
Not yet reported University of Erlangen-Nürnberg Medical School 11 participants Est. completion 2019-01-15 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT03174691
Early Luteal Progesterone Profile in IVF Patients Triggered With hCG
Not yet reported Vietnam National University 161 participants Est. completion 2017-08-08 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03178695
Inovium Ovarian Rejuvenation Trials
Not yet reported Ascendance Biomedical 200 participants Est. completion 2018-05-01 1 siteOther conditions: Perimenopausal Disorder, Menopause, Menopause, Premature, Menopause Related Conditions, Menopause Premature Symptomatic, Menopause Premature Asymptomatic, Premature Ovarian Failure, Premature Ovarian Failure, Familial, Premature Ovarian Failure 2A, Premature Ovarian Failure 3, Premature Ovarian Failure 4, Premature Ovarian Failure 1, Premature Ovarian Failure 5, Premature Ovarian Failure 6, Premature Ovarian Failure 7, Premature Ovarian Failure 9, Premature Ovarian Failure 8, Infertility, Infertility, Female, Infertility UnexplainedView official trial listing → -
Completed NCT NCT03179904
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
Not yet reported Mayo Clinic 17 participants Est. completion 2026-03-13 3 sitesOther conditions: Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, HER2-positive Breast CancerView official trial listing → -
Withdrawn NCT NCT03197571
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28Other conditions: Urothelial CarcinomaView official trial listing → -
Withdrawn NCT NCT03197584
QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28Other conditions: Ovarian CancerView official trial listing → -
Status unknown NCT NCT03202862
The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer
Not yet reported Fudan University 50 participants Est. completion 2019-08-01Other conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT03204318
SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Not yet reported Myovant Sciences GmbH 638 participants Est. completion 2021-04-08 123 sitesOther conditions: Endometriosis Related PainView official trial listing → -
Completed NCT NCT03204331
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Not yet reported Myovant Sciences GmbH 623 participants Est. completion 2021-05-31 91 sitesOther conditions: Endometriosis Related PainView official trial listing → -
Completed NCT NCT03213457
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
Not yet reported AbbVie 681 participants Est. completion 2023-12-06 197 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT03232281
Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis
Not yet reported Ipsen 300 participants Est. completion 2019-11-16 24 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT03236740
OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS
Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2018-03-15 1 siteOther conditions: PCOSView official trial listing → -
Status unknown NCT NCT03237117
Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program
Not yet reported Competence Centre on Health Technologies 105 participants Est. completion 2017-12-31 1 siteOther conditions: Female InfertilityView official trial listing → -
Completed NCT NCT03238196
Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 35 participants Est. completion 2024-03-20 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT03241810
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Not yet reported Elevation Oncology 22 participants Est. completion 2018-11-30 59 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03249402
A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants
Not yet reported Janssen-Cilag International NV 24 participants Est. completion 2017-11-24 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03262740
The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2018-01-30 2 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT03264638
A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS
Not yet reported Aijun Sun 315 participants Est. completion 2018-08-31 1 siteOther conditions: PCOSView official trial listing → -
Completed NCT NCT03271489
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Not yet reported AbbVie 478 participants Est. completion 2024-06-28 157 sitesOther conditions: Heavy Menstrual Bleeding, Uterine FibroidsView official trial listing → -
Status unknown NCT NCT03274765
Improved Medically Assisted Procreation Monitoring
Rennes University Hospital 30 participants Est. completion 2018-12-15 1 siteOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT03289039
Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer
Not yet reported Dana-Farber Cancer Institute 21 participants Est. completion 2021-07-20 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03294538
Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis
Not yet reported Actavis Inc. 663 participants Est. completion 2017-02-15 44 sitesOther conditions: Atrophic VaginitisView official trial listing → -
Terminated NCT NCT03294694
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Not yet reported Dana-Farber Cancer Institute 33 participants Est. completion 2020-10-14 3 sitesOther conditions: Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian CancerView official trial listing → -
Completed NCT NCT03300518
Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient
Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 552 participants Est. completion 2021-08-18 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03301233
Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women
Not yet reported Ain Shams University 90 participants Est. completion 2018-07-30 1 siteOther conditions: Endometrial ThicknessView official trial listing → -
Completed NCT NCT03321981
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.
Not yet reported Merus B.V. 105 participants Est. completion 2023-07-26 25 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT03322852
Effect of Clomiphene Citrate on Uterine Blood Fow in Women With Unexplained Delayed Conception
Cairo University 50 participants Est. completion 2016-10-30 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT03324685
A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen
Not yet reported Biogen 36 participants Est. completion 2018-03-15 1 siteOther conditions: Drug InteractionsView official trial listing → -
Status unknown NCT NCT03329898
Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion
Not yet reported Beijing Obstetrics and Gynecology Hospital 200 participants Est. completion 2018-11-25 1 siteOther conditions: Intrauterine AdhesionView official trial listing → -
Completed NCT NCT03333564
Effect of Vitamin D3 and Omega-3FA on Estradiol
Not yet reported Applied Science Private University 116 participants Est. completion 2017-02Other conditions: Vitamin D DeficiencyView official trial listing → -
Terminated NCT NCT03343067
A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
Not yet reported AbbVie 11 participants Est. completion 2018-10-23 37 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT03344536
A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 10 participants Est. completion 2021-08-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03346317
Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-05-20 1 siteOther conditions: Intrauterine AdhesionView official trial listing → -
Status unknown NCT NCT03351205
The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-11-22 1 siteOther conditions: Intrauterine AdhesionView official trial listing → -
Completed NCT NCT03353857
Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
Not yet reported Bayer 68 participants Est. completion 2019-02-19 2 sitesOther conditions: Biological AvailabilityView official trial listing → -
Completed NCT NCT03355651
Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction
Not yet reported OPKO Health, Inc. 80 participants Est. completion 2017-03-03Other conditions: ACL ReconstructionView official trial listing → -
Completed NCT NCT03359057
Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel
Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 36 participants Est. completion 2013-09-17 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT03361969
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
Not yet reported Pantarhei Oncology B.V. 63 participants Est. completion 2020-05-15 6 sitesOther conditions: Prostatic NeoplasmView official trial listing → -
Completed NCT NCT03363828
The Temporo-spatial Dynamics of Genital Tract Microbiota
Peter Humaidan 27 participants Est. completion 2021-01-08 2 sitesOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT03363893
Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies
Not yet reported, Not yet reported Carrick Therapeutics Limited 124 participants Est. completion 2022-12-15 23 sitesOther conditions: Advanced Solid MalignanciesView official trial listing → -
Status unknown NCT NCT03373149
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
Not yet reported Riyadh Fertility and Reproductive Health center 228 participants Est. completion 2020-11 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT03385551
Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
Instituto Palacios 120 participants Est. completion 2020-09-30 2 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Active, not recruiting NCT NCT03393845
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
Not yet reported Nancy Chan, MD 47 participants Est. completion 2027-09-01 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03395665
Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer
Fundacion Dexeus 299 participants Est. completion 2018-01 1 siteOther conditions: Infertility, Preimplantation Genetic Diagnosis/Screening, MiscarriageView official trial listing → -
Completed NCT NCT03395756
Depot Medroxyprogesterone Acetate as Emergency Contraception
Not yet reported University of Southern California 30 participants Est. completion 2020-10-30 1 siteOther conditions: Emergency Contraception, ContraceptionView official trial listing → -
Completed NCT NCT03412890
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Not yet reported Myovant Sciences GmbH 477 participants Est. completion 2021-01-13 150 sitesOther conditions: Heavy Menstrual Bleeding, Uterine FibroidView official trial listing → -
Completed NCT NCT03418363
How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills
Not yet reported Oregon Health and Science University 15 participants Est. completion 2019-12-11 1 siteOther conditions: Contraceptive Usage, CoagulationView official trial listing → -
Active, not recruiting NCT NCT03425838
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
Not yet reported Borstkanker Onderzoek Groep 1050 participants Est. completion 2028-12 72 sitesOther conditions: Breast Neoplasm FemaleView official trial listing → -
Status unknown NCT NCT03442504
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
Not yet reported Institut Cancerologie de l'Ouest 57 participants Est. completion 2024-06 4 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03443089
Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate
Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 24 participants Est. completion 2017-08-01 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT03451110
Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects
Not yet reported Eisai Inc. 50 participants Est. completion 2018-03-23 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT03462251
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
Not yet reported iOMEDICO AG 41 participants Est. completion 2022-11-30 27 sitesOther conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast CancerView official trial listing → -
Completed NCT NCT03470610
Administration of Vaginal and Rectal Progesterone During FET Cycles
Thor Haahr 277 participants Est. completion 2019-09-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03498313
Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality
Not yet reported University of Illinois Chicago 60 participants Est. completion 2021-05-09 1 site Stand-aloneOther conditions: Suicidal IdeationView official trial listing → -
Withdrawn NCT NCT03506399
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
Not yet reported Eli Lilly and Company Est. completion 2018-10 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT03531437
Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT
Not yet reported Mahidol University 112 participants Est. completion 2018-04-18Other conditions: Contraception, HypercoagulabilityView official trial listing → -
Active, not recruiting NCT NCT03531645
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2027-09-30 1 siteOther conditions: Malignant Neoplasms of Female Genital OrgansView official trial listing → -
Status unknown NCT NCT03544762
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
Not yet reported National Taiwan University Hospital 60 participants Est. completion 2020-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03554044
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
Not yet reported University of California, San Francisco 20 participants Est. completion 2023-12-31 1 siteOther conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Breast CarcinomaView official trial listing → -
Completed NCT NCT03555877
Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2022-07-21 1 siteOther conditions: Breast Cancer MetastaticView official trial listing → -
Status unknown NCT NCT03556800
Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.
Not yet reported Viramal Limited 20 participants Est. completion 2022-06-30 1 siteOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT03557619
A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies
Not yet reported AbbVie 12 participants Est. completion 2026-03-21 4 sitesOther conditions: Hematologic MalignanciesView official trial listing → -
Status unknown NCT NCT03560856
A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer
Not yet reported Assistance Publique - Hôpitaux de Paris 54 participants Est. completion 2022-06-01Other conditions: Breast Cancer, HR+/HER2-negative Breast Cancer, MetastasisView official trial listing → -
Completed NCT NCT03578172
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 186 participants Est. completion 2019-11-20 1 siteOther conditions: Infertility, Female, Intrauterine AdhesionView official trial listing → -
Terminated NCT NCT03584009
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy
Not yet reported Hoffmann-La Roche 103 participants Est. completion 2021-05-06 40 sitesOther conditions: Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03584971
Estrogen and Cooperation, Competitiveness, and Risk Preferences
RWTH Aachen University 80 participants Est. completion 2021-12-30 1 siteOther conditions: Behavioral Correlates of EstradiolView official trial listing → -
Status unknown NCT NCT03591549
Fulvestrant in Metastatic Breast Cancer
Not yet reported Assiut University 30 participants Est. completion 2021-10-01Other conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03620643
Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
Not yet reported Royal Marsden NHS Foundation Trust 33 participants Est. completion 2024-08-30 5 sitesOther conditions: Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer, CDH1 Gene MutationView official trial listing → -
Status unknown NCT NCT03620929
Estrogen in the Prevention of Adhesion Reformation
Not yet reported Fu Xing Hospital, Capital Medical University 186 participants Est. completion 2022-12-01 1 siteOther conditions: Asherman SyndromeView official trial listing → -
Completed NCT NCT03633331
Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 93 participants Est. completion 2026-02-27 447 sitesOther conditions: Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Active, not recruiting NCT NCT03640624
Multidisciplinary Treatment of Chronic Vulvar Pain
Not yet reported Norwegian University of Science and Technology 106 participants Est. completion 2027-06 1 siteOther conditions: Vulvodynia, Chronic PainView official trial listing → -
Completed NCT NCT03642665
Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer
Not yet reported Universitaire Ziekenhuizen KU Leuven 554 participants Est. completion 2024-11-01 1 siteOther conditions: Embryo TransferView official trial listing → -
Completed NCT NCT03643510
Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 27 participants Est. completion 2026-03-12 7 sitesOther conditions: Adenocarcinoma of EndometriumView official trial listing → -
Completed NCT NCT03652623
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study
Not yet reported, Not yet reported Hektoen Institute for Medical Research 49 participants Est. completion 2023-11-30 1 siteOther conditions: HIV/AIDS, Gender, Behavior and Behavior MechanismsView official trial listing → -
Completed NCT NCT03662516
A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects
Not yet reported Pfizer 17 participants Est. completion 2019-01-19 1 siteOther conditions: Healthy FemalesView official trial listing → -
Completed NCT NCT03685331
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 siteOther conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 MutationView official trial listing → -
Completed NCT NCT03689543
Estrogen Receptor Beta and Mood
Not yet reported National Institute of Mental Health (NIMH) 74 participants Est. completion 2024-09-09 1 siteOther conditions: Perimenopause-Related DepressionView official trial listing → -
Completed NCT NCT03691493
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT03720847
Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality
Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2017-11 1 siteOther conditions: Suicidal IdeationView official trial listing → -
Withdrawn NCT NCT03724955
Pilot E2 for Hypogonadal Women With CFBD
Not yet reported Emory University Est. completion 2021-06 1 siteOther conditions: Cystic Fibrosis Related Bone DiseaseView official trial listing → -
Terminated NCT NCT03725696
The Effect of Bariatric Surgery on Spermatogenesis
The Cleveland Clinic 25 participants Est. completion 2020-12-31 1 siteOther conditions: Bariatric Surgery Candidate, Sexual Function and Fertility DisordersView official trial listing → -
Completed NCT NCT03726931
FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET
Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2023-01-29 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT03749733
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate
Not yet reported Grünenthal GmbH Est. completion 2019-12 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT03751124
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Not yet reported Myovant Sciences GmbH 229 participants Est. completion 2021-10-20 104 sitesOther conditions: Uterine Leiomyoma, Uterine FibroidsView official trial listing → -
Completed NCT NCT03767335
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
Not yet reported Menarini Group 62 participants Est. completion 2024-02-23 27 sitesOther conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03773263
New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome
Not yet reported Sun Yat-sen University 300 participants Est. completion 2020-03 5 sitesOther conditions: Polycystic Ovary Syndrome, InfertilityView official trial listing → -
Completed NCT NCT03778931
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Not yet reported Stemline Therapeutics, Inc. 478 participants Est. completion 2024-08-22 244 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03779633
Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse
Not yet reported Medical University of Vienna 120 participants Est. completion 2020-08-27 2 sitesOther conditions: Pelvic Organ ProlapseView official trial listing → -
Completed NCT NCT03783897
A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects
Not yet reported Enanta Pharmaceuticals, Inc 43 participants Est. completion 2019-06-18 1 siteMASHView official trial listing → -
Status unknown NCT NCT03788681
Luteal Phase Support With Estradiol In Poor Responders Undergoing In Vitro Fertilization
Not yet reported Ain Shams University 170 participants Est. completion 2019-09-01 1 siteOther conditions: ICSIView official trial listing → -
Status unknown NCT NCT03789123
Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma
Not yet reported Bagcilar Training and Research Hospital 710 participants Est. completion 2019-12-01 1 siteOther conditions: Ovarian ReserveView official trial listing → -
Completed NCT NCT03809546
Individual Differences in Drug Response
Not yet reported University of Chicago 60 participants Est. completion 2021-06-01 1 siteOther conditions: Differential Female Response to Δ9-tetrahydrocannabinol (THC)View official trial listing → -
Completed NCT NCT03815929
Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women
Not yet reported Mayo Clinic 35 participants Est. completion 2023-08-28 1 siteOther conditions: Cardiovascular Risk ReductionView official trial listing → -
Completed NCT NCT03819140
Continuous Versus Cyclical OCP Use in PCOS
Not yet reported University of California, San Francisco 51 participants Est. completion 2022-10-16 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Status unknown NCT NCT03832894
Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .
Not yet reported Cairo University 2 participants Est. completion 2020-01-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03837223
RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER
Istituto Clinico Humanitas 271 participants Est. completion 2016-12-31Other conditions: GnRH Trigger and Rescue ProtocolView official trial listing → -
Completed NCT NCT03848234
Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder
Not yet reported Tangent Data 209 participants Est. completion 2016-07-29 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisordersView official trial listing → -
Completed NCT NCT03854903
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor
Not yet reported Georgetown University 19 participants Est. completion 2025-01-09 1 siteOther conditions: Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast CancerView official trial listing → -
Withdrawn NCT NCT03856268
Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause
Pennington Biomedical Research Center Est. completion 2022-11-11 1 siteOther conditions: Menopause Surgical, Estrogen Deficiency, Adiposity, Follicle-Stimulating Hormone Deficiency, Hormone DeficiencyView official trial listing → -
Completed NCT NCT03876145
The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome
Not yet reported Royan Institute 120 participants Est. completion 2020-11-20 1 siteOther conditions: Polycystic Ovary Syndrome, Ovarian Hyperstimulation SyndromeView official trial listing → -
Completed NCT NCT03887728
Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles
ART Fertility Clinics LLC 124 participants Est. completion 2020-12-14 1 siteOther conditions: Endometrial ReceptivityView official trial listing → -
Completed NCT NCT03901131
PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.
Bayer 296 participants Est. completion 2022-02-17 1 siteOther conditions: ContraceptiveView official trial listing → -
Completed NCT NCT03921710
CAPA-IVM Versus STANDARD IVM
Not yet reported Mỹ Đức Hospital 80 participants Est. completion 2018-10-10 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Status unknown NCT NCT03925233
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital 300 participants Est. completion 2021-12-15 1 siteOther conditions: Breast Cancer OrganoidsView official trial listing → -
Completed NCT NCT03926936
FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study
Not yet reported Frederic Amant 17 participants Est. completion 2022-12-27 14 sitesObstructive sleep apnea Other conditions: Endometrial Stromal Sarcoma, Endometrial Cancer, Sex Cord Stromal Tumor, Serous Ovarian TumorView official trial listing → -
Status unknown NCT NCT03927456
A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 357 participants Est. completion 2022-12-30 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT03930706
SHorter Treatment of Replacement Therapy for Frozen Embryo Transfer (FET)
Not yet reported Universitair Ziekenhuis Brussel 150 participants Est. completion 2021-03-31 1 siteOther conditions: InfertilityView official trial listing → -
Active, not recruiting NCT NCT03939897
Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2027-07-31 14 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma, Recurrent Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT03941730
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Not yet reported Mayo Clinic 8 participants Est. completion 2026-12-31 9 sitesOther conditions: Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Recurrent Breast CarcinomaView official trial listing → -
Completed NCT NCT03945513
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
Not yet reported Insud Pharma 1034 participants Est. completion 2023-09-08 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT03945812
Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer
Not yet reported Wael Elbanna Clinic 665 participants Est. completion 2023-03-08 1 siteOther conditions: Infertility, Frozen Embryo Transfer (FET)View official trial listing → -
Terminated NCT NCT03976544
Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients
Not yet reported CRG UZ Brussel 362 participants Est. completion 2025-01-01 1 siteOther conditions: Miscarriage, Frozen Embryo Transfer, Natural Cycle, Hormone Replacement Therapy Cycle, Preimplantation Genetic Screening, Euploid EmbryosView official trial listing → -
Status unknown NCT NCT03981341
Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea
Not yet reported Laval University 36 participants Est. completion 2023-12-01 1 siteOther conditions: Sleep Apnea, Post Menopausal, Oxidative StressView official trial listing → -
Completed NCT NCT03998761
Progesterone Versus Progesterone Plus Dydrogesterone in FET
Not yet reported Mỹ Đức Hospital 1364 participants Est. completion 2021-01-31 1 siteOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT04002635
Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)
Not yet reported CRG UZ Brussel Est. completion 2022-04-01Other conditions: Infertility, Female, Polycystic Ovary Syndrome, IVF, Ovulation DisorderView official trial listing → -
Completed NCT NCT04013438
Luteal Phase Support During Frozen Embryo Transfer Cycle
Not yet reported Royan Institute 60 participants Est. completion 2019-04-30 1 siteOther conditions: Infertility, Female, Frozen Embryo TransferView official trial listing → -
Completed NCT NCT04018274
Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids
Not yet reported Pfizer 29 participants Est. completion 2019-10-16 2 sitesOther conditions: HealthyView official trial listing → -
Withdrawn NCT NCT04021017
PRE-GAiN Bone Health Pilot Study
Not yet reported University of Saskatchewan Est. completion 2022-12-13 1 siteObstructive sleep apneaView official trial listing → -
Status unknown NCT NCT04034589
Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive,HR-Positive Metastatic Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46 participants Est. completion 2022-07-06 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT04050592
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Not yet reported Hanna Savolainen-Peltonen 150 participants Est. completion 2022-12 1 siteCardiovascular disease Other conditions: Menopause, Atherosclerosis, Estrogen Replacement TherapyView official trial listing → -
Completed NCT NCT04051320
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
Not yet reported University of North Carolina, Chapel Hill 23 participants Est. completion 2022-07-19 1 siteOther conditions: Perinatal Depression, Post Partum Depression, Depression, Postpartum, DepressionView official trial listing → -
Completed NCT NCT04055129
Hormone Induced Effects on Ligament Laxity and Lower Extremity Motor Control
University of St. Augustine for Health Sciences 52 participants Est. completion 2023-08-01 1 siteOther conditions: Hormone Influence on Ligament Laxity and Motor ControlView official trial listing → -
Terminated NCT NCT04059484
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Terminated NCT NCT04060862
A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer
Not yet reported Hoffmann-La Roche 20 participants Est. completion 2023-08-29 20 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04066283
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
University of Colorado, Denver 29 participants Est. completion 2023-12-31 1 siteOther conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive BehaviorView official trial listing → -
Completed NCT NCT04079218
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
Not yet reported Kerry Murphy 60 participants Est. completion 2023-08-09 1 siteOther conditions: HIV Infection, Vaginal Atrophy, Menopause, Menopause Related Conditions, Aging, Premature Aging, Atrophic Vaginitis, Dysbiosis, VaginitisView official trial listing → -
Completed NCT NCT04090957
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)
Not yet reported Estetra 1015 participants Est. completion 2022-08-18 117 sitesOther conditions: Vasomotor Symptoms, Menopausal SymptomsView official trial listing → -
Status unknown NCT NCT04092673
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Not yet reported, Not yet reported Effector Therapeutics 30 participants Est. completion 2025-03-31 14 sitesOther conditions: Solid Tumor, AdultView official trial listing → -
Terminated NCT NCT04092829
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 591 participants Est. completion 2022-12-31 1 siteOther conditions: Pre-Eclampsia, Frozen Embryo TransferView official trial listing → -
Status unknown NCT NCT04100655
The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium
Not yet reported Sir Run Run Shaw Hospital 96 participants Est. completion 2020-12 1 siteOther conditions: Thin EndometriumView official trial listing → -
Active, not recruiting NCT NCT04103476
Advancing Postmenopausal Preventive Therapy
Not yet reported University of Southern California 385 participants Est. completion 2026-12-31 1 siteOther conditions: Atherosclerosis, Cognitive DeclineView official trial listing → -
Completed NCT NCT04107129
Predicting Endometrial Receptivity for Optimal Reproductive Management
Stanford University 76 participants Est. completion 2024-07-30 1 siteOther conditions: Infertility, Female, EndometriosisView official trial listing → -
Completed NCT NCT04112368
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
Not yet reported University of Illinois Chicago 124 participants Est. completion 2024-08-01 1 site Stand-aloneOther conditions: Suicidal IdeationView official trial listing → -
Terminated NCT NCT04131517
A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants
Not yet reported UCB Biopharma SRL 14 participants Est. completion 2020-05-22 1 siteOther conditions: Healthy Female ParticipantsView official trial listing → -
Completed NCT NCT04150731
16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer
Not yet reported, Not yet reported University of Aarhus 8 participants Est. completion 2023-06-28 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04172987
A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
Not yet reported Eli Lilly and Company 40 participants Est. completion 2021-02-09 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04190927
A New Hormone Replacement Paradigm: Physiologic Restoration Study
Not yet reported Women's Hormone Network 100 participants Est. completion 2023-08-01Other conditions: Menopause, Perimenopausal Disorder, Menopause Related ConditionsView official trial listing → -
Completed NCT NCT04193852
Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2019-11-25 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT04194905
Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2020-12-15 1 siteOther conditions: BioequivalenceView official trial listing → -
Enrolling by invitation NCT NCT04202094
Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems
Not yet reported Universitair Ziekenhuis Brussel 50 participants Est. completion 2030-12 1 siteOther conditions: Childhood Cancer, Hematological DisordersView official trial listing → -
Completed NCT NCT04209543
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
Not yet reported Estetra 1570 participants Est. completion 2024-02-08 224 sitesOther conditions: Vasomotor Symptoms, Menopausal SymptomsView official trial listing → -
Completed NCT NCT04209881
Ovarian Reserve and Ankylosing Spondylitis
Kanuni Sultan Suleyman Training and Research Hospital 50 participants Est. completion 2020-05-19 1 siteOther conditions: Ovarian Diseases, Ankylosing Spondylitis, Anti-Mullerian Hormone DeficiencyView official trial listing → -
Completed NCT NCT04230070
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 30 participants Est. completion 2020-11-17 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT04247126
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
Not yet reported Syros Pharmaceuticals 105 participants Est. completion 2023-03-30 16 sitesOther conditions: Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer, Pancreatic CancerView official trial listing → -
Status unknown NCT NCT04247204
Assessment of Endometrial and Sub-endometrial Vascularity Before and After PRP Infusion in Frozen Embryo Transfer Cycles
Not yet reported Hatem AbuHashim 30 participants Est. completion 2020-10-05Other conditions: Frozen Embryo TransferView official trial listing → -
Completed NCT NCT04258163
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 760 participants Est. completion 2019-07-01 3 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04259996
Impact of Serum Progesterone in Modified Natural Cycles and Stimulated Cycles on Ongoing Pregnancy Rate
Instituto Valenciano de Infertilidad, IVI VALENCIA 488 participants Est. completion 2023-07-01 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT04267250
Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids
Not yet reported Pfizer 18 participants Est. completion 2020-11-06 2 sitesOther conditions: Healthy Female VolunteersView official trial listing → -
Completed NCT NCT04272008
The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
Not yet reported TherapeuticsMD 21 participants Est. completion 2021-06-08 2 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT04278053
Evaluation of Sports Supplements on Blood Flow
Not yet reported University of Arkansas, Fayetteville 24 participants Est. completion 2019-05-08 1 siteOther conditions: Determine the Effects of Nitrosigine and Citrulline-malate on Flow-mediated Dilation Among Young AdultsView official trial listing → -
Terminated NCT NCT04278755
Binge Eating & Birth Control
Not yet reported University of North Carolina, Chapel Hill 8 participants Est. completion 2022-05-17 1 siteObstructive sleep apnea Other conditions: Binge Eating, Eating Disorders, Binge-Eating DisorderView official trial listing → -
Withdrawn NCT NCT04280523
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH
Vanderbilt University Medical Center Est. completion 2023-12-31 1 siteOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Status unknown NCT NCT04283435
Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium
Not yet reported Cairo University 100 participants Est. completion 2022-03-01 1 siteOther conditions: IVF, Endometrial ReceptivityView official trial listing → -
Status unknown NCT NCT04289974
Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer
Chinese Academy of Medical Sciences 100 participants Est. completion 2022-04 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04300790
Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT04305236
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer
Not yet reported University of California, Irvine 1 participants Est. completion 2022-02-16 1 siteOther conditions: Breast Neoplasm, Hormone Receptor Positive Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT04305496
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
Not yet reported AstraZeneca 818 participants Est. completion 2026-06-22 215 sitesOther conditions: Locally Advanced (Inoperable) or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04309643
Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects
Not yet reported Concert Pharmaceuticals 21 participants Est. completion 2020-07-08 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04330677
Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin
Not yet reported University Hospital, Bonn 487 participants Est. completion 2020-01-25 1 siteOther conditions: Oxytocin, Estrogen, Fear Extinction, Emotion Processing, MemoryView official trial listing → -
Completed NCT NCT04352777
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
Not yet reported Duke University 18 participants Est. completion 2025-06-25 1 siteOther conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive TumorView official trial listing → -
Status unknown NCT NCT04355520
A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 42 participants Est. completion 2021-09 4 sitesOther conditions: HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerView official trial listing → -
Terminated NCT NCT04359329
Estrogen Patch for COVID-19 Symptoms
Not yet reported Sharon Nachman 2 participants Est. completion 2020-07-30 1 siteOther conditions: COVIDView official trial listing → -
Completed NCT NCT04418908
Estrogen, Diabetes, and Endothelial Function
Not yet reported University of Colorado, Denver 40 participants Est. completion 2018-10-22Other conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT04423068
Inpatient Adolescent Contraception
Not yet reported Children's Mercy Hospital Kansas City 25 participants Est. completion 2023-04-04 1 siteOther conditions: Pregnancy Related, Contraception, Contraceptive Usage, Contraception Behavior, PregnancyView official trial listing → -
Status unknown NCT NCT04433897
Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women
University Hospital, Ghent 300 participants Est. completion 2025-12-31 1 siteOther conditions: NocturiaView official trial listing → -
Completed NCT NCT04445025
Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis
Not yet reported Colorado Center for Reproductive Medicine 30 participants Est. completion 2024-12-30 1 siteOther conditions: Infertility, EndometriosisView official trial listing → -
Status unknown NCT NCT04447872
The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol
Not yet reported Northwell Health 142 participants Est. completion 2025-06 1 siteOther conditions: Infertility, Diminished Ovarian Reserve, IVFView official trial listing → -
Status unknown NCT NCT04453332
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
Not yet reported Hospital de Clinicas de Porto Alegre 60 participants Est. completion 2021-12 1 siteOther conditions: Menopause, Hormone Replacement TherapyView official trial listing → -
Terminated NCT NCT04454749
Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes
ART Fertility Clinics LLC 3 participants Est. completion 2021-03-04 1 siteOther conditions: Endometrial Disorder, Infertility, Female, IVF, Pregnancy EarlyView official trial listing → -
Completed NCT NCT04482920
Effect of Hormone Therapy on Renal Function
University of Colorado, Denver 22 participants Est. completion 2023-08-31 1 siteOther conditions: Transgenderism, Kidney Diseases, Kidney InjuryView official trial listing → -
Completed NCT NCT04483505
Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.
Not yet reported Fundacion CRIS de Investigación para Vencer el Cáncer 9 participants Est. completion 2023-04-04 8 sitesOther conditions: Breast Cancer Metastatic, Hormone Receptor Positive Malignant Neoplasm of BreastView official trial listing → -
Withdrawn NCT NCT04498520
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
Not yet reported Pamela Munster Est. completion 2025-06-30Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Endometrioid Adenocarcinoma, Metastatic Fallopian Tube Carcinoma, Metastatic HER2 Negative Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Refractory Breast Carcinoma, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8, Stage IV Uterine Corpus Cancer AJCC v8, Stage IVA Fallopian Tube Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVA Primary Peritoneal Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Fallopian Tube Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8, Stage IVB Primary Peritoneal Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8View official trial listing → -
Withdrawn NCT NCT04503161
The Effect of an ASC-seeded Collagen Hydrogel on Cerebrospinal Fluid Leak Rates Following Skull Base Surgery
Not yet reported Stanford University Est. completion 2022-09Other conditions: CSF LeakView official trial listing → -
Status unknown NCT NCT04503915
Estrogen Supplementation Mode in HRT-FET Cycle: a RCT
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 784 participants Est. completion 2023-12-01Other conditions: Hormone Replacement Therapy, Estrogen, Live Birth RateView official trial listing → -
Completed NCT NCT04508582
Cardiac and Immune Cell Function in Preeclampsia
Queen Mary University of London 86 participants Est. completion 2024-03-06 1 siteCardiovascular disease Other conditions: Preeclampsia, Hypertension, Pregnancy Induced Hypertension, Pregnancy Related, Cardiovascular Risk Factor, Heart DiseasesView official trial listing → -
Status unknown NCT NCT04513405
Estrogens Levels and Receptors Status and Skin Tears
Not yet reported University of Catanzaro 1200 participants Est. completion 2022-09-01 1 siteOther conditions: Skin Tear, Estrogen DeficiencyView official trial listing → -
Active, not recruiting NCT NCT04524000
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2027-02-27 15 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT04537078
Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders
Not yet reported El Shatby University Hospital for Obstetrics and Gynecology 90 participants Est. completion 2021-09-01 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Status unknown NCT NCT04539626
Estrogen Therapy in Non-severe COVID-19 Patients
Not yet reported CMN "20 de Noviembre" 44 participants Est. completion 2023-12-31 1 siteOther conditions: Covid-19View official trial listing → -
Active, not recruiting NCT NCT04544189
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 69 participants Est. completion 2027-01-29 24 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT04544475
A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause
Not yet reported NYU Langone Health 49 participants Est. completion 2022-10-03 1 siteOther conditions: Genitourinary Syndrome of Menopause (GSM)View official trial listing → -
Active, not recruiting NCT NCT04553133
PF-07104091 as a Single Agent and in Combination Therapy
Not yet reported Pfizer 157 participants Est. completion 2026-12-31 22 sitesOther conditions: Small Cell Lung Cancer, Ovarian Cancer, Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04567420
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Not yet reported Criterium, Inc. 70 participants Est. completion 2028-12-31 19 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04572295
A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer
Not yet reported Eisai Co., Ltd. 51 participants Est. completion 2026-06-18 11 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT04574999
Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.
Not yet reported Italfarmaco S.A 167 participants Est. completion 2009-02-23 12 sitesOther conditions: Vaginal AtrophyView official trial listing → -
Active, not recruiting NCT NCT04576455
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
Not yet reported Hoffmann-La Roche 303 participants Est. completion 2027-08-25 81 sitesOther conditions: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04579380
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Not yet reported Seagen, a wholly owned subsidiary of Pfizer 217 participants Est. completion 2026-12-31 108 sitesOther conditions: Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms, Carcinoma, Non-Small-Cell Lung, HER2 Mutations Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT04590417
Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women
Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 siteOther conditions: Drug InteractionView official trial listing → -
Completed NCT NCT04603183
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
Not yet reported MedSIR 162 participants Est. completion 2025-06-30 31 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT04616417
Investigational Oocyte Cryopreservation for Medical and Non Medical Indications
Not yet reported University of Illinois Chicago 29 participants Est. completion 2023-03-20 1 siteOther conditions: Infertility, Female, Deferred ChildbearingView official trial listing → -
Status unknown NCT NCT04616729
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 30 participants Est. completion 2025-12-31 2 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT04641624
sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency
Cengiz Gokcek Women's and Children's Hospital 90 participants Est. completion 2021-08-30 1 siteOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Active, not recruiting NCT NCT04650581
Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
Not yet reported Canadian Cancer Trials Group 250 participants Est. completion 2026-12-31 39 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04714554
A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men
Not yet reported Myovant Sciences GmbH 43 participants Est. completion 2021-03-29 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT04738292
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2023-05-15 2 sitesOther conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic CancerView official trial listing → -
Completed NCT NCT04746313
Prevalence of Hyperprolactinemia in Systemic Scleroderma
University Hospital, Lille 71 participants Est. completion 2021-05-12 1 siteOther conditions: Sclerosis, Systemic, Scleroderma, HyperprolactinemiaView official trial listing → -
Completed NCT NCT04760691
Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
Not yet reported Johns Hopkins University 13 participants Est. completion 2025-03-24 1 siteOther conditions: HIV, Prophylaxis, TransgenderView official trial listing → -
Active, not recruiting NCT NCT04762979
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer
Not yet reported Marina N Sharifi 44 participants Est. completion 2026-05 4 sitesOther conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04769401
Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle
Not yet reported Bezmialem Vakif University 238 participants Est. completion 2021-11-21 2 sitesOther conditions: Infertility, IVF, ProgesteroneView official trial listing → -
Completed NCT NCT04778514
A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention
Not yet reported Population Council 30 participants Est. completion 2023-09-11 1 siteOther conditions: HIV Infections, ContraceptionView official trial listing → -
Completed NCT NCT04796623
A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122 participants Est. completion 2024-05-24 17 sitesOther conditions: HR-positive, HER2-negative Advanced Breast CancerView official trial listing → -
Completed NCT NCT04819906
Effect of Estetrol Monohydrate (E4) on QTc Interval
Not yet reported Estetra 32 participants Est. completion 2021-07-14 1 siteOther conditions: Prolonged QTc IntervalView official trial listing → -
Completed NCT NCT04821375
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
Not yet reported Carol Fabian, MD 16 participants Est. completion 2024-12-31 1 siteOther conditions: Increased Risk for Development of Breast CancerView official trial listing → -
Completed NCT NCT04822857
The Impact of Menopause on the Development of Heart Failure and Organ Damage of Hypertension
Polish Mother Memorial Hospital Research Institute 86 participants Est. completion 2020-12-30 1 siteOther conditions: Hypertension, MenopauseView official trial listing → -
Completed NCT NCT04828824
Premature Discontinuation of Contraceptive Implants
Not yet reported University of Colorado, Denver 600 participants Est. completion 2025-11-12 1 siteOther conditions: Contraception BehaviorView official trial listing → -
Completed NCT NCT04841499
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
Not yet reported University of South Alabama 40 participants Est. completion 2021-07-15 1 siteOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT04852081
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Blokhin's Russian Cancer Research Center 1000 participants Est. completion 2021-12-01 1 siteOther conditions: Breast Cancer Stage IVView official trial listing → -
Status unknown NCT NCT04853069
Oestrogen Treatment for COVID-19 Symptoms
Not yet reported Hamad Medical Corporation 2000 participants Est. completion 2022-03-31 1 siteOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04856306
Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L
Medstar Health Research Institute 300 participants Est. completion 2025-08-30 1 siteOther conditions: Heavy Menstrual Bleeding, Fibroid UterusView official trial listing → -
Terminated NCT NCT04862143
Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant
Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2022-09-19 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04862663
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Not yet reported AstraZeneca 893 participants Est. completion 2029-08-14 225 sitesOther conditions: Locally Advanced (Inoperable) or Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT04865029
Estradiol and Progesterone in Hospitalized COVID-19 Patients
Not yet reported Tulane University 10 participants Est. completion 2022-01-25 1 siteOther conditions: Covid19View official trial listing → -
Terminated NCT NCT04899349
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant
Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2023-05-10 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04899778
Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes
Not yet reported Cedars-Sinai Medical Center 73 participants Est. completion 2024-06-30 1 siteOther conditions: Ligament InjuryView official trial listing → -
Completed NCT NCT04901377
A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest
Bayer 255 participants Est. completion 2023-04-20 1 siteOther conditions: Oral ContraceptionView official trial listing → -
Completed NCT NCT04916509
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region
Pfizer 258 participants Est. completion 2022-12-27 7 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT04920708
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
Not yet reported Royal Marsden NHS Foundation Trust 57 participants Est. completion 2027-06 13 sitesOther conditions: Metastatic Breast Cancer, ER+ Breast Cancer, Advanced Breast CancerView official trial listing → -
Completed NCT NCT04923867
Suturable DuraGen™ PMCF Study
Integra LifeSciences Corporation 106 participants Est. completion 2024-07-31 3 sitesOther conditions: Cerebrospinal Fluid LeakView official trial listing → -
Withdrawn NCT NCT04933240
Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial
Not yet reported Virginia Commonwealth University Est. completion 2024-12 2 sitesOther conditions: Vaginal BleedingView official trial listing → -
Completed NCT NCT04934696
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2022-01-25 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Status unknown NCT NCT04936295
Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation
Not yet reported Sun Yat-sen University 61 participants Est. completion 2025-06-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04942015
Honghuaruyi Wan for Endometriosis Dysmenorrhea
Not yet reported Beijing University of Chinese Medicine 164 participants Est. completion 2023-12-31Other conditions: Endometriosis, DysmenorrheaView official trial listing → -
Status unknown NCT NCT04962386
Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD
Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2022-03-06 2 sitesOther conditions: Meibomian Gland DysfunctionView official trial listing → -
Terminated NCT NCT04967248
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting
Novartis Pharmaceuticals 4 participants Est. completion 2024-10-18Other conditions: Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA MutationView official trial listing → -
Completed NCT NCT04972396
Pemvidutide (ALT-801) DDI Study in Healthy Volunteers
Not yet reported Altimmune, Inc. 40 participants Est. completion 2022-05-15 2 sitesMASHView official trial listing → -
Completed NCT NCT04979091
Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients
Universitätsklinikum Hamburg-Eppendorf 100 participants Est. completion 2021-05-31 1 siteOther conditions: Covid19, Critical IllnessView official trial listing → -
Completed NCT NCT04989348
Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol
Not yet reported Shanghai First Maternity and Infant Hospital 240 participants Est. completion 2024-02-20 1 siteOther conditions: IVFView official trial listing → -
Completed NCT NCT04997525
Estradiol and Progesterone Levels Following Frozen Embryo Transfer
Not yet reported Copenhagen University Hospital at Herlev 305 participants Est. completion 2024-12-06 1 siteOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT04999540
Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer
Not yet reported Guangdong Women and Children Hospital 73 participants Est. completion 2024-12-30Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT05002738
Desogestrel-containing COCP Pharmacokinetic Validation Study
Not yet reported University of Colorado, Denver 22 participants Est. completion 2022-11-28 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT05010707
Transgender Estradiol Affirming Therapy
Not yet reported Washington University School of Medicine 39 participants Est. completion 2024-01-01 1 siteOther conditions: TransgenderismView official trial listing → -
Status unknown NCT NCT05021094
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
Not yet reported Affiliated Hospital of Nantong University 120 participants Est. completion 2023-12-31 6 sitesOther conditions: Primary Ovarian InsufficiencyView official trial listing → -
Status unknown NCT NCT05047848
Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer
Not yet reported Liaoning Cancer Hospital & Institute 82 participants Est. completion 2023-09-18 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT05054374
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 6 participants Est. completion 2023-10-26 4 sitesOther conditions: Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer, Solid Carcinoma, MEK1 Gene Mutation, MEK2 Gene Mutation, Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05063786
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in PIK3CA-mutated HER2+ Advanced BC (ALPHABET)
Not yet reported Spanish Breast Cancer Research Group 27 participants Est. completion 2025-12-23 106 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT05064332
A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)
Not yet reported Pfizer 10 participants Est. completion 2021-12-16 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT05065411
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Not yet reported Veru Inc. 5 participants Est. completion 2024-01-09 30 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT05073237
Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans
Not yet reported VA Office of Research and Development Est. completion 2024-04-08 1 sitePrediabetes Other conditions: Menopause, ObesityView official trial listing → -
Status unknown NCT NCT05076695
Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer
Not yet reported Fudan University 37 participants Est. completion 2024-10-15 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-positive Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05077449
A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer
Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 300 participants Est. completion 2029-11 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Terminated NCT NCT05085002
A Study of Lerociclib in Participants With Advanced Breast Cancer
Not yet reported EQRx, Inc. 100 participants Est. completion 2023-11-29 21 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05090358
Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 15 participants Est. completion 2027-10-08 9 sitesOther conditions: Breast Cancer, Breast Cancer Stage IV, Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05096065
Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
Not yet reported Enteris BioPharma Inc. 16 participants Est. completion 2022-05 4 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT05098574
Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder
Not yet reported St. Joseph's Healthcare Hamilton 17 participants Est. completion 2024-04-11 1 siteOther conditions: Premenstrual Dysphoric Disorder, Bipolar DisorderView official trial listing → -
Status unknown NCT NCT05112692
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
Not yet reported Mansoura University 200 participants Est. completion 2023-12Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesView official trial listing → -
Status unknown NCT NCT05116371
Control of Bleeding on Nexplanon in Latinx Patients
University of Arizona 144 participants Est. completion 2024-12-01Other conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT05143723
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
Not yet reported Kuban State Medical University 102 participants Est. completion 2022-06-10 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT05153564
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
Not yet reported Novo Nordisk A/S 27 participants Est. completion 2022-09-01 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT05156879
Aspirin for the Management of Endometriosis-associated Pelvic Pain
Not yet reported Women's Hospital School Of Medicine Zhejiang University 220 participants Est. completion 2025-06 1 siteOther conditions: Pelvic PainView official trial listing → -
Active, not recruiting NCT NCT05161195
Roll-over Study to Allow Continued Access to Ribociclib
Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2030-08-14 73 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05161338
Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study.
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 100 participants Est. completion 2023-04-30 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Active, not recruiting NCT NCT05169567
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
Not yet reported Eli Lilly and Company 368 participants Est. completion 2027-12 138 sitesOther conditions: Breast Neoplasm, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT05184777
Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 120 participants Est. completion 2023-02-20 1 siteOther conditions: Infertility, Female, Reproductive SterilityView official trial listing → -
Status unknown NCT NCT05186545
An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
Not yet reported The First Affiliated Hospital of Zhengzhou University 63 participants Est. completion 2025-07 5 sitesOther conditions: Breast Cancer, Breast Cancer FemaleView official trial listing → -
Completed NCT NCT05189145
Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles
Not yet reported Alexandria University 600 participants Est. completion 2021-10-01 1 siteOther conditions: Female InfertilityView official trial listing → -
Completed NCT NCT05197374
Effect of Estradiol Pretreatment on Antagonist ICSI Cycles
Not yet reported Alexandria University 114 participants Est. completion 2021-11-15 1 siteOther conditions: Female InfertilityView official trial listing → -
Terminated NCT NCT05207709
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
Not yet reported SOLTI Breast Cancer Research Group 61 participants Est. completion 2026-03-26 71 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05227391
Live Birth After Letrozole-stimulated Cycles Versus Hormone Replacement Treatment Cycles for the First Frozen Embryo Transfer in Women With PCOS
Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 1078 participants Est. completion 2024-12-31 1 siteOther conditions: PCOSView official trial listing → -
Completed NCT NCT05243823
Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy
Novo Nordisk A/S 500000 participants Est. completion 2022-07-31 1 siteOther conditions: Postmenopausal Vaginal AtrophyView official trial listing → -
Terminated NCT NCT05252416
(VELA) Study of BLU-222 in Advanced Solid Tumors
Not yet reported Blueprint Medicines Corporation 50 participants Est. completion 2025-07-04 23 sitesObstructive sleep apnea Other conditions: Advanced Solid Tumors, HR+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer, Ovarian Cancer, Endometrial Cancer, Gastric Cancer, Esophageal AdenocarcinomaView official trial listing → -
Terminated NCT NCT05264506
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
Not yet reported Organon and Co 3055 participants Est. completion 2024-01-26 103 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT05282940
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 36 participants Est. completion 2022-04-08 1 siteOther conditions: Therapeutic EquivalencyView official trial listing → -
Status unknown NCT NCT05300841
The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"
Not yet reported Sohag University 500 participants Est. completion 2023-05-01Other conditions: PCOS, ICSIView official trial listing → -
Status unknown NCT NCT05302726
Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
Not yet reported Copenhagen University Hospital, Rigshospitalet 20 participants Est. completion 2023-06-01 1 siteOther conditions: Adrenal Insufficiency, Hypogonadism FemaleView official trial listing → -
Active, not recruiting NCT NCT05306340
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
Not yet reported Genentech, Inc. 373 participants Est. completion 2027-06-15 136 sitesOther conditions: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05307133
Oxytocin and Sleeve Gastrectomy
Not yet reported Centre Hospitalier Universitaire de Nice 20 participants Est. completion 2025-03-04 1 siteOther conditions: Obesity, MorbidView official trial listing → -
Active, not recruiting NCT NCT05307705
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Not yet reported Eli Lilly and Company 260 participants Est. completion 2026-12 50 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT05317364
Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery
Not yet reported University of Alabama at Birmingham 38 participants Est. completion 2026-02-13 1 siteOther conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary IncontinenceView official trial listing → -
Active, not recruiting NCT NCT05319873
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
Not yet reported, Not yet reported Jonsson Comprehensive Cancer Center 18 participants Est. completion 2028-04-01 1 siteOther conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Locally Advanced HER2-Positive Breast Carcinoma, Metastatic HER2-Positive Breast Carcinoma, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT05360576
An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study
Not yet reported Lupin Research Inc 40 participants Est. completion 2022-07-04 1 siteOther conditions: Pregnancy PreventionView official trial listing → -
Terminated NCT NCT05384119
Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
Not yet reported Tvardi Therapeutics, Incorporated 6 participants Est. completion 2024-05-06 6 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT05387577
Coagulation and Fibrinolysis of Estradiol in Transwomen
Not yet reported Medical College of Wisconsin 6 participants Est. completion 2022-11-23 1 siteOther conditions: Transgenderism, Clotting DisorderView official trial listing → -
Active, not recruiting NCT NCT05392608
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
Not yet reported Borstkanker Onderzoek Groep 130 participants Est. completion 2028-03 25 sitesOther conditions: Neoplasm, Breast, Congenital, Familial and Genetic DisordersView official trial listing → -
Completed NCT NCT05418426
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
Not yet reported Daré Bioscience, Inc. 34 participants Est. completion 2022-01-27 2 sitesOther conditions: Vulvovaginal Atrophy, Vasomotor SymptomsView official trial listing → -
Completed NCT NCT05427617
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
Hunan Cancer Hospital 223 participants Est. completion 2021-06-30Other conditions: Metastatic Breast Cancer, Circulating Tumor DNA, Gene AbnormalityView official trial listing → -
Terminated NCT NCT05428215
Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients
Not yet reported MaineHealth 2 participants Est. completion 2023-07-20 1 siteOther conditions: Gender DysphoriaView official trial listing → -
Active, not recruiting NCT NCT05463601
Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 132 participants Est. completion 2026-12-31 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05469204
Effect of Estrogen Treatment on Drug Metabolism and Transport
Not yet reported University of Washington 22 participants Est. completion 2025-07-30 1 siteOther conditions: Transgender PersonsView official trial listing → -
Completed NCT NCT05472779
Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections
Not yet reported Stephanie Wang Zuo 114 participants Est. completion 2025-06-25 4 sitesOther conditions: Recurrent Urinary Tract InfectionView official trial listing → -
Completed NCT NCT05505162
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
Not yet reported AstraZeneca 24 participants Est. completion 2023-01-10 1 siteOther conditions: Healthy Female ParticipantsView official trial listing → -
Status unknown NCT NCT05545592
Reduced Oestrogen Dosage to Improve the Outcome of Frozen-thawed Embryo Transfer
Not yet reported Nanjing University 660 participants Est. completion 2026-06-01 1 siteOther conditions: FETView official trial listing → -
Completed NCT NCT05551949
Preventing Recurrent UTI With Vaginal Estrogen
Not yet reported Johns Hopkins University 27 participants Est. completion 2025-08-31 1 siteOther conditions: Recurrent Urinary Tract Infection, Urinary Tract Infections, Cystitis RecurrentView official trial listing → -
Status unknown NCT NCT05574881
Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer
Not yet reported, Not yet reported Fudan University 72 participants Est. completion 2025-01-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05577923
Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)
Not yet reported Fudan University 126 participants Est. completion 2026-03-01 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05579574
A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants
Not yet reported Bristol-Myers Squibb 42 participants Est. completion 2023-06-01 2 sitesOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT05586711
Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
Not yet reported Angelica Lindén Hirschberg 170 participants Est. completion 2024-12-15 1 siteOther conditions: Vulvovaginal Atrophy, Genitourinary Syndrome of MenopauseView official trial listing → -
Completed NCT NCT05613777
A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood
Not yet reported Boehringer Ingelheim 19 participants Est. completion 2023-10-04 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT05620355
Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
Not yet reported Bio Genuine (Shanghai) Biotech Co., Ltd. 312 participants Est. completion 2025-03 29 sitesOther conditions: Uterine Fibroids, Heavy Menstrual BleedingView official trial listing → -
Active, not recruiting NCT NCT05654623
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
Not yet reported Pfizer 624 participants Est. completion 2028-05-15 312 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT05657171
"Effect of CPA/EE Drug on Periodontal Tissue and hsCRP Levels in PCOS Patients With Gingivitis
Postgraduate Institute of Dental Sciences Rohtak 47 participants Est. completion 2023-12-30 1 siteOther conditions: Periodontal DiseasesView official trial listing → -
Completed NCT NCT05678192
Effect of Menopausal Hormone Therapy on Immune System Parameters
Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 40 participants Est. completion 2023-03-01 1 siteOther conditions: Last Period Not Earlier Than 6 Months AgoView official trial listing → -
Status unknown NCT NCT05683119
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
Not yet reported Western University, Canada 20 participants Est. completion 2024-12 1 siteOther conditions: Menstrual Cycle, Oral ContraceptivesView official trial listing → -
Completed NCT NCT05706753
A Study of Milvexian in Healthy Adult Females
Not yet reported Janssen Pharmaceutica N.V., Belgium 20 participants Est. completion 2023-07-20 1 siteOther conditions: Healthy FemaleView official trial listing → -
Terminated NCT NCT05716139
Natural Cycle vs Programmed Cycle Frozen Embryo Transfer
Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 siteOther conditions: Infertility, Frozen Embryo Transfer, Preeclampsia and EclampsiaView official trial listing → -
Status unknown NCT NCT05716152
Hormonal Associations in Male Patients With Psoriasis Vulgaris
Sohag University 102 participants Est. completion 2024-08-01Other conditions: Psoriasis VulgarisView official trial listing → -
Active, not recruiting NCT NCT05723601
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
Not yet reported Wake Forest University Health Sciences 21 participants Est. completion 2027-01 1 siteOther conditions: Recurrent Urinary Tract InfectionView official trial listing → -
Active, not recruiting NCT NCT05738213
Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine
Not yet reported Washington University School of Medicine 100 participants Est. completion 2028-01-01 1 siteOther conditions: MigraineView official trial listing → -
Active, not recruiting NCT NCT05739136
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
Sumitomo Pharma Switzerland GmbH 530 participants Est. completion 2027-05 1 siteOther conditions: Pregnancy Related, Pregnancy Complications, Pregnancy, High RiskView official trial listing → -
Completed NCT NCT05753098
Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility
Not yet reported Beni-Suef University 148 participants Est. completion 2023-01-31 1 siteOther conditions: Subfertility, FemaleView official trial listing → -
Completed NCT NCT05759949
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
Not yet reported Relay Therapeutics, Inc. 41 participants Est. completion 2025-04-11 7 sitesOther conditions: PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Solid Tumor, Hormone Receptor Positive TumorView official trial listing → -
Completed NCT NCT05774405
Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients
Not yet reported Istanbul University - Cerrahpasa 9169 participants Est. completion 2021-07-31 1 site Stand-aloneOther conditions: COVID-19, Hormone Replacement TherapyView official trial listing → -
Status unknown NCT NCT05780489
Evaluation of Salivary ELISA for Hormone Monitoring in Donors
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 200 participants Est. completion 2024-12 2 sitesOther conditions: Infertility, Female, Reproductive SterilityView official trial listing → -
Status unknown NCT NCT05792410
A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.
Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 300 participants Est. completion 2025-02-27Other conditions: HER2 Low Advanced or Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05802303
Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation
Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 siteOther conditions: Frozen Embryo Transfer, Infertility, FemaleView official trial listing → -
Status unknown NCT NCT05806047
Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy
Not yet reported Fudan University 23 participants Est. completion 2024-11-01Other conditions: Hormone Receptor-positive Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT05806671
Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy
Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2025-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05835089
Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
Sohag University 50 participants Est. completion 2024-05 1 siteChronic kidney diseaseView official trial listing → -
Completed NCT NCT05894954
Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment
Not yet reported Alzheimer's Prevention and Reversal Project, Inc. 73 participants Est. completion 2026-02-09 6 sitesOther conditions: Mild Cognitive Impairment, Dementia, MildView official trial listing → -
Status unknown NCT NCT05903716
The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris
Marmara University 40 participants Est. completion 2023-06-30 1 siteOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT05903820
Rhythmic Estradiol and Bone Health
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 48 participants Est. completion 2024-10-28 1 siteOther conditions: Osteoporosis Risk, MenopauseView official trial listing → -
Terminated NCT NCT05932667
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Not yet reported Institut Curie 1 participants Est. completion 2023-11-30 6 sitesOther conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05966584
A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 1 participants Est. completion 2024-08-02 7 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05985590
A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants
Not yet reported Bristol-Myers Squibb 37 participants Est. completion 2023-12-11 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT05994599
Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring
Not yet reported Evestra Inc. 36 participants Est. completion 2023-12-11 1 siteOther conditions: Healthy Women, Female, ContraceptionView official trial listing → -
Terminated NCT NCT06005610
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 93 participants Est. completion 2025-08-21 18 sitesOther conditions: HIV I InfectionView official trial listing → -
Status unknown NCT NCT06026553
Assessing Ketorolac (Toradol) at Oocyte Retrieval
Not yet reported Shady Grove Fertility Reproductive Science Center 400 participants Est. completion 2025-01 2 sitesOther conditions: Infertility, Infertility, Female, Oocyte Retrieval, Postoperative Pain, Embryo TransferView official trial listing → -
Completed NCT NCT06039826
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
Not yet reported Eli Lilly and Company 46 participants Est. completion 2024-07-11 2 sitesOther conditions: OverweightView official trial listing → -
Active, not recruiting NCT NCT06065748
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Not yet reported Hoffmann-La Roche 1050 participants Est. completion 2029-02-12 311 sitesOther conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06110793
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 56 participants Est. completion 2027-11 7 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06132620
Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons
Not yet reported Yun Chen 60 participants Est. completion 2018-06-30 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT06136208
Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women
Not yet reported Science Valley Research Institute 20 participants Est. completion 2025-07-30 1 siteOther conditions: Climacteric Syndrome, Menopause, HypoestrogenismView official trial listing → -
Completed NCT NCT06144814
A Comparison of Hyaluronic Acid and Estradiol Treatment in Vulvovaginal Atrophy.
Not yet reported Koru Health Groups 300 participants Est. completion 2023-09-30 1 siteOther conditions: Vulvovaginal AtrophyView official trial listing → -
Terminated NCT NCT06191289
Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
Not yet reported University of Illinois Chicago 11 participants Est. completion 2024-12-01 1 site Stand-aloneOther conditions: SuicideView official trial listing → -
Status unknown NCT NCT06204016
Estradiol and Stress Reactivity in Women
International Research Training Group 2804 74 participants Est. completion 2025-12 1 siteOther conditions: Stress vs. Control, Estradiol vs. PlaceboView official trial listing → -
Status unknown NCT NCT06233071
Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®
Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-02 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT06250205
Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib
Not yet reported NewAmsterdam Pharma 30 participants Est. completion 2024-04-26 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT06253195
BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Not yet reported BeOne Medicines 33 participants Est. completion 2026-04-23 7 sitesOther conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Hormone-receptor-positive Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, HER2-negative Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Not yet reported BeiGene 103 participants Est. completion 2027-08-27 24 sitesOther conditions: Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, Prostate Cancer, TNBC - Triple-Negative Breast Cancer, GastroEsophageal Cancer, Bladder CancerView official trial listing → -
Withdrawn NCT NCT06279195
Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
Not yet reported Endeavor Health Est. completion 2025-11-02 1 siteOther conditions: Pelvic PainView official trial listing → -
Not yet recruiting NCT NCT06306404
Sleeping Through Menopause
Not yet reported VU University of Amsterdam 222 participants Est. completion 2030-01-01Other conditions: Menopause, InsomniaView official trial listing → -
Completed NCT NCT06308614
Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women
Not yet reported Estetra 82 participants Est. completion 2025-04-21 24 sitesOther conditions: Sexual Dysfunction, PhysiologicalView official trial listing → -
Completed NCT NCT06310616
A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants
Not yet reported ViiV Healthcare 26 participants Est. completion 2024-08-15 1 siteOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT06312033
Estradiol's Effect on Brain Volume and Connectivity
Not yet reported International Research Training Group 2804 32 participants Est. completion 2021-12-31 1 siteOther conditions: Emotion Regulation, EstradiolView official trial listing → -
Completed NCT NCT06316219
The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation
Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sitesOther conditions: Endometrial Polyp, Endometrial DiseasesView official trial listing → -
Not yet recruiting NCT NCT06318403
Estradiol Supplementation and Rotator Cuff Repair
Not yet reported University of Utah 58 participants Est. completion 2030-12 Stand-aloneOther conditions: Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome, Menopause Related Conditions, MenopauseView official trial listing → -
Active, not recruiting NCT NCT06353269
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
Not yet reported University of California, Irvine 111 participants Est. completion 2027-09 1 siteOther conditions: Recurrent Urinary Tract Infection, HypoestrogenismView official trial listing → -
Completed NCT NCT06354257
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
Not yet reported GlaxoSmithKline 20 participants Est. completion 2024-07-01 1 siteOther conditions: TuberculosisView official trial listing → -
Not yet recruiting NCT NCT06369363
Estrogen Deficiency on Cardiovascular Risk
Not yet reported Milton S. Hershey Medical Center 20 participants Est. completion 2028-11 Stand-aloneCardiovascular disease Other conditions: Postmenopausal SymptomsView official trial listing → -
Completed NCT NCT06375707
First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer
Not yet reported The First Affiliated Hospital with Nanjing Medical University 74 participants Est. completion 2026-05-30 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT06396208
"Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
Not yet reported Chulalongkorn University 40 participants Est. completion 2024-10-20 1 siteOther conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal ProfileView official trial listing → -
Completed NCT NCT06396221
"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
Not yet reported Chulalongkorn University 36 participants Est. completion 2024-09-30 1 siteOther conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal ProfileView official trial listing → -
Terminated NCT NCT06408168
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)
Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2025-12-08 1 siteOther conditions: Hormone Receptor-positive Human Epidermal Growth Factor 2-negative, Metastatic Invasive LObular CarcinomaView official trial listing → -
Completed NCT NCT06426771
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital 90 participants Est. completion 2024-11-10 1 siteOther conditions: AMH, Diet Habit, Ovarian Failure, Polycystic Ovary SyndromeView official trial listing → -
Active, not recruiting NCT NCT06428396
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
Not yet reported Merck Sharp & Dohme LLC 120 participants Est. completion 2028-12-25 41 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06447623
Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
Not yet reported Fudan University 184 participants Est. completion 2029-02-01 1 siteOther conditions: Advanced Breast Cancer, HR+/HER2- Breast CancerView official trial listing → -
Completed NCT NCT06461039
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
Not yet reported Novo Nordisk A/S 43 participants Est. completion 2025-04-04 1 siteOther conditions: ObesityView official trial listing → -
Not yet recruiting NCT NCT06480682
Relative Energy Deficiency in Sport and Dance
University of Wolverhampton 200 participants Est. completion 2029-07-30 1 siteOther conditions: Relative Energy Deficiency in Sport, Bone Stress ReactionView official trial listing → -
Active, not recruiting NCT NCT06494150
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 siteOther conditions: Low Grade Ovarian Serous AdenocarcinomaView official trial listing → -
Active, not recruiting NCT NCT06506955
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Not yet reported, Not yet reported Taiho Oncology, Inc. 15 participants Est. completion 2027-04-30 9 sitesOther conditions: Advanced/Metastatic CancerView official trial listing → -
Completed NCT NCT06525675
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
MedSIR 419 participants Est. completion 2024-09-02 36 sitesOther conditions: Metastatic Breast Cancer, Advanced Breast Cancer, Luminal Breast Cancer, HER2-negative Breast Cancer, ER-positive Breast CancerView official trial listing → -
Status unknown NCT NCT06546397
Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
Not yet reported Women's Hospital School Of Medicine Zhejiang University 200 participants Est. completion 2025-12-31 1 siteOther conditions: Pregnancy ComplicationsView official trial listing → -
Status unknown NCT NCT06577974
Role of Medical Treatment in Endometriosis Patients Undergoing ICSI
Not yet reported Cairo University 129 participants Est. completion 2025-03-01 2 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT06654570
Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial
Not yet reported Helsinki University Central Hospital 20 participants Est. completion 2024-10-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT06671405
An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions
Not yet reported AstraZeneca 59 participants Est. completion 2025-02-17 1 siteOther conditions: DyslipidaemiaView official trial listing → -
Active, not recruiting NCT NCT06680921
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 482 participants Est. completion 2028-08-31 57 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT06691815
Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism
Not yet reported Hospital de Niños R. Gutierrez de Buenos Aires 48 participants Est. completion 2026-09 1 siteOther conditions: Pubertal Delay, Hypogonadism, Hypogonadotropic, Constitutional Delay in Growth and Puberty (CDGP)View official trial listing → -
Completed NCT NCT06773429
Estradiol and Brain Age
International Research Training Group 2804 32 participants Est. completion 2019-07-31 1 siteOther conditions: Estradiol (E2) Vs. Placebo (PLAC), EstradiolView official trial listing → -
Completed NCT NCT06778733
Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders
Not yet reported University of Athens 22 participants Est. completion 2024-04-30 2 sitesOther conditions: Female InfertilityView official trial listing → -
Completed NCT NCT06780163
Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder
Not yet reported Mahidol University 30 participants Est. completion 2025-11-11 1 siteOther conditions: Overactive Bladder (OAB), Menopause, MicrobiomeView official trial listing → -
Completed NCT NCT06799884
A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives
Not yet reported Idorsia Pharmaceuticals Ltd. 19 participants Est. completion 2025-02-21 1 siteOther conditions: Drug Drug InteractionView official trial listing → -
Completed NCT NCT06820307
Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants
Not yet reported Vertex Pharmaceuticals Incorporated 50 participants Est. completion 2025-04-29 1 siteOther conditions: PainView official trial listing → -
Completed NCT NCT06942936
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
Not yet reported AstraZeneca 51 participants Est. completion 2026-01-28 2 sitesOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07007416
Impact of Supraphysiological Estradiol on ECG in IVF Patients
Konya City Hospital 62 participants Est. completion 2025-01-31 1 siteOther conditions: In Vitro Fertilization, Estradiol, Cardiac Electrophysiology, Electrocardiography (ECG), Reproductive EndocrinologyView official trial listing → -
Active, not recruiting NCT NCT07013643
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
Not yet reported AstraZeneca 100 participants Est. completion 2027-07-09 2 sitesOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07027332
Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
Bezmialem Vakif University 36 participants Est. completion 2025-03-08 1 siteOther conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver DiseaseView official trial listing → -
Active, not recruiting NCT NCT07038369
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Not yet reported Atavistik Bio, Inc 134 participants Est. completion 2029-01-31 8 sitesOther conditions: Advanced Solid Tumors, Breast Cancer, Breast Carcinoma, Breast Neoplasms, ER Positive Breast Cancer, Cervical Cancers, Cervical Neoplasms, Cervical Carcinoma, Triple Negative Breast Cancer, Gynecologic Cancers, Gynecologic Neoplasm, Endometrial Cancer, Endometrial Neoplasm, Endometrial Carcinoma (EC), Fallopian Cancer, Ovarian Carcinoma, Ovarian Cancer, Ovarian Neoplasms, Prostate Cancers, Prostate Carcinoma, Solid Tumors, Neoplasms, Neoplasms by Site, Breast Diseases, Uterine Neoplasms, Genital Neoplasms, Female, Urogenital NeoplasmsView official trial listing → -
Not yet recruiting NCT NCT07041814
A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases
Not yet reported Universiti Kebangsaan Malaysia Medical Centre 24 participants Est. completion 2029-10-31 1 siteOther conditions: Turner SyndromeView official trial listing → -
Completed NCT NCT07074327
Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants
Not yet reported Vertex Pharmaceuticals Incorporated 74 participants Est. completion 2026-02-27 1 siteOther conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)View official trial listing → -
Completed NCT NCT07096024
A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market
Pfizer 95637 participants Est. completion 2025-02-07 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT07103603
MHT and Liver Function in Postmenopausal Women
Not yet reported Ipek B. Ozcivit Erkan, MD 44 participants Est. completion 2025-12-30 1 siteOther conditions: Menopause, Non Alcholic Fatty Liver Disease, Hepatic SteatosisView official trial listing → -
Completed NCT NCT07145281
Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study
Not yet reported Tel-Aviv Sourasky Medical Center 30 participants Est. completion 2024-11-10 1 siteOther conditions: Gender Dysphoria, Adult, Blood Coagulation, Coagulation Factors, Transgender Persons, M01.777.500, Hemostasis, Transgender WomenView official trial listing → -
Not yet recruiting NCT NCT07179939
Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
Not yet reported Fudan University 288 participants Est. completion 2031-12-30 1 siteOther conditions: HER2-positive Breast CancerView official trial listing → -
Active, not recruiting NCT NCT07204093
Ultra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 138 participants Est. completion 2026-02 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT07215806
Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive
Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 20 participants Est. completion 2022-11-25 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT07229209
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
Not yet reported Benha University 166 participants Est. completion 2025-11-01 1 siteOther conditions: Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine ScarView official trial listing → -
Not yet recruiting NCT NCT07235618
A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer
Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 siteOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT07235774
A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants
Not yet reported Institut de Recherches Internationales Servier (I.R.I.S.) 28 participants Est. completion 2026-03-13 1 siteOther conditions: Healthy Adult Female ParticipantsView official trial listing → -
Not yet recruiting NCT NCT07260825
Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial
Not yet reported, Not yet reported TriHealth Inc. 44 participants Est. completion 2026-08 2 sitesOther conditions: Vulvodynia, Dyspareunia, Lichen Sclerosus of VulvaView official trial listing → -
Completed NCT NCT07269327
An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin
Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 24 participants Est. completion 2026-03-09 1 siteOther conditions: FertilityView official trial listing → -
Completed NCT NCT07272889
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Not yet reported Atea Pharmaceuticals, Inc. 24 participants Est. completion 2026-02-17 1 siteOther conditions: Healthy Volunteer StudyView official trial listing → -
Not yet recruiting NCT NCT07288190
Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
Not yet reported HIV Prevention Trials Network 300 participants Est. completion 2028-05-15 3 sitesOther conditions: Pregnancy, HIV InfectionsView official trial listing → -
Completed NCT NCT07318337
Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2025-06-30 1 siteOther conditions: PCOS (Polycystic Ovary Syndrome)View official trial listing → -
Not yet recruiting NCT NCT07328789
Factors Influencing Cardiac Rehabilitation Success
Pomeranian Medical University Szczecin 150 participants Est. completion 2029-07-01Other conditions: RehabilitationView official trial listing → -
Not yet recruiting NCT NCT07340619
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
Not yet reported UNICANCER 51 participants Est. completion 2029-11-18 8 sitesOther conditions: Metastatic (Stage IV) MelanomaView official trial listing → -
Not yet recruiting NCT NCT07366632
A Study of Single Dose of BL0175 in Postmenopausal Women
Not yet reported Shanghai Best-Link Bioscience, LLC 27 participants Est. completion 2026-12-21Other conditions: Postmenopausal WomenView official trial listing → -
Not yet recruiting NCT NCT07393321
A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer
Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 210 participants Est. completion 2031-08-31Other conditions: HR Positive/HER2 Negative Advanced or Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT07408089
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
Not yet reported Boundless Bio, Inc. 8 participants Est. completion 2026-07-28 8 sitesOther conditions: Breast Cancer, Metastatic Breast Cancer, Advanced Breast CancerView official trial listing → -
Completed NCT NCT07414784
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
Not yet reported AbbVie 20 participants Est. completion 2026-08-04 2 sitesOther conditions: Healthy VolunteerView official trial listing → -
Not yet recruiting NCT NCT07480681
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor
Not yet reported Shanghai Henlius Biotech 138 participants Est. completion 2028-06Other conditions: Advanced/Metastatic Solid TumorsView official trial listing → -
Not yet recruiting NCT NCT07496294
Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy
Not yet reported Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 200 participants Est. completion 2027-10 1 site Stand-aloneOther conditions: Menopausal Women, Menopausal Symptom Relief, Hormone Therapy, Menopausal Hormone TherapyView official trial listing → -
Completed NCT NCT07509411
Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI
Not yet reported Benha University 145 participants Est. completion 2026-08-07 1 siteOther conditions: EndometriosisView official trial listing → -
Active, not recruiting NCT NCT07523711
Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity
Not yet reported Amgen 49 participants Est. completion 2026-11-18 2 sitesOther conditions: Overweight, ObesityView official trial listing → -
Active, not recruiting NCT NCT07525791
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
Not yet reported Novo Nordisk A/S 41 participants Est. completion 2027-06-18 1 siteOther conditions: Overweight, ObesityView official trial listing → -
Completed NCT NCT07526207
Estradiol 8 vs 12 mg for Endometrial Preparation in HRT-FET
Not yet reported Cairo University 850 participants Est. completion 2026-02-26 2 sitesOther conditions: Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Frozen Embryo Transfer (FET), Endometrial Preparation, Clinical Pregnancy RatesView official trial listing → -
Not yet recruiting NCT NCT07526948
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
Not yet reported Albert Einstein College of Medicine 62 participants Est. completion 2029-10-14 1 siteOther conditions: Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related Conditions, Vaginitis, PerimenopauseView official trial listing → -
Completed NCT NCT07539090
Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
Not yet reported Deciphera Pharmaceuticals, LLC 27 participants Est. completion 2026-10-08 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Not yet recruiting NCT NCT07544966
Teen Vulnerability to Irritability: Brain and Estrogen Changes
Not yet reported University of North Carolina, Chapel Hill 50 participants Est. completion 2029-04 2 sitesOther conditions: Depression - Major Depressive Disorder, IrritabilityView official trial listing → -
Not yet recruiting NCT NCT07618390
A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 160 participants Est. completion 2028-12Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT07656792
A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood
Not yet reported Boehringer Ingelheim 8 participants Est. completion 2026-09-23 1 siteOther conditions: HealthyView official trial listing → -
Not yet recruiting NCT NCT07679269
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2032-04-20Other conditions: PIK3CA-Related Overgrowth Spectrum (PROS), Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation)View official trial listing → -
Not yet recruiting NCT NCT07714616
Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)
Not yet reported Eurofarma Laboratorios S.A. 1600 participants Est. completion 2030-05-31 1 siteOther conditions: ContraceptionView official trial listing → -
Not yet recruiting NCT NCT07724145
Association Between Female Hormonal Profile and Wound Healing
University Hospital, Geneva 84 participants Est. completion 2028-12 1 siteOther conditions: Wound Healing, Wound Healing Complication, EstradiolView official trial listing → -
Not yet recruiting NCT NCT07729046
Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 siteOther conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07732452
Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 100 participants Est. completion 2029-01 Stand-aloneCardiovascular disease Other conditions: Menopause, Perimenopause, Vasomotor Symptoms, Menopausal Hormone Therapy, Cardiac Remodeling, Myocardial Fibrosis, Microvascular Dysfunction, Cognitive Function AssessmentView official trial listing → -
Not yet recruiting NCT NCT07737613
Acute Effects of Estradiol Administration on Brain Function During Fear Learning
Not yet reported University of Arizona 30 participants Est. completion 2027-12Other conditions: PTSD and Trauma-related Symptoms, Cognitive Decline in Older Adults, Post Menopausal WomenView official trial listing → -
Active, not recruiting NCT NCT07754630
Analysis of the Hormonal Implant and Transdermal Estradiol Gel in Climacteric Women
Not yet reported Nutrindo Ideais Research Center 50 participants Est. completion 2027-10-01 1 siteOther conditions: Menopause, Hypoestrogenism, Hormonal TherapyView official trial listing → -
Completed NCT NCT07763847
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 siteOther conditions: EndometriomaView official trial listing → -
Completed NCT NCT07770594
Effect of Dienogest in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 siteOther conditions: EndometriomaView official trial listing → -
Not yet recruiting NCT NCT07784036
JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer
Not yet reported Chengdu JOYO pharma Co., Ltd. 171 participants Est. completion 2029-06-30Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07787520
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors
Not yet reported Laekna Limited 150 participants Est. completion 2029-12 6 sitesOther conditions: Patients With Advanced Solid TumorsView official trial listing → -
Not yet recruiting NCT NCT07811232
A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers
Not yet reported, Not yet reported Advenchen Pharmaceuticals, LLC. 138 participants Est. completion 2031-09-01 1 siteOther conditions: Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast NeoplasmsView official trial listing → -
Not yet recruiting NCT NCT07818278
Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)
Not yet reported University Hospital, Ghent 70 participants Est. completion 2029-08-31 1 site Stand-aloneOther conditions: Fertility, Implantation, EmbryoView official trial listing → -
Completed NCT NCT07821086
Effects of Estrogen Therapy on Lipid Metabolism and Insulin Sensitivity in Hypogonadal Women
Not yet reported Khyber Medical University Peshawar 30 participants Est. completion 2026-09-20 1 siteOther conditions: Female HypogonadismView official trial listing → -
Completed NCT NCT07851649
A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants
Not yet reported Corium Innovations, Inc. 68 participants Est. completion 2026-09-29 1 site Stand-aloneOther conditions: Healthy Female Participants, PostmenopauseView official trial listing → -
Completed NCT NCT07854873
Vaginal Prasterone Versus Estriol in Women With Pelvic Floor Disorders
Not yet reported Poznan University of Medical Sciences 74 participants Est. completion 2026-01-31 1 siteOther conditions: Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI)View official trial listing → -
Not yet recruiting NCT NCT07857226
Trastuzumab/Pertuzumab With Fulvestrant and Culmerciclib in HR+/HER2+ Early Breast Cancer
Not yet reported Hebei Medical University Fourth Hospital 31 participants Est. completion 2028-12Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07867262
A Study to Evaluate the Effects of GDC-4198 in Combination With Letrozole, Fulvestrant, or Giredestrant in Participants With Locally Advanced or Metastatic Hormone Receptor-Positive, HER2-Negatve Breast Cancer
Not yet reported Genentech, Inc. 165 participants Est. completion 2030-08-15Other conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07868536
Post-traumatic Estradiol Administration and Care Evaluation (PEACE)
Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2028-07-31Other conditions: Chronic Musculoskeletal Pain, Sexual Assault, Posttraumatic Stress Disorder (PTSD)View official trial listing → -
Completed NCT NCT07891793
Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation
Not yet reported Assisting Nature 180 participants Est. completion 2026-06-30 1 siteOther conditions: Infertile Patient Undergoing ICSI ProcedureView official trial listing → -
Not yet recruiting NCT NCT07897721
A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors
Not yet reported Pfizer 268 participants Est. completion 2032-03-21 5 sitesOther conditions: Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Metastatic Colorectal AdenocarcinomaView official trial listing → -
Not yet recruiting NCT NCT07908901
Integrated Care Pathway for Hormonally Mediated Vestibulodynia: a Feasibility and Acceptability Pilot
Not yet reported HerAccess ApS 35 participants Est. completion 2027-12 2 sitesOther conditions: Vestibulodynia, Vulvodynia, Vulvar VestibulitisView official trial listing → -
Completed NCT NCT07911709
Effect of Combined Hormonal Contraceptiveson Free Androgen Index (FAI) in Polycystic Ovary Syndrome:Drospirenone-Ethinyl Estradiol (DRSP-EE) Versus Cyproterone Acetate-Ethinyl Estradiol (CPA-EE)
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2024-12-31 1 siteOther conditions: PCOS (Polycystic Ovary Syndrome)View official trial listing → -
Not yet recruiting NCT NCT07919054
Serum Estradiol and Endometrial Thickness After Bariatric Surgery in Postmenopausal Women With Obesity
Kasr El Aini Hospital 78 participants Est. completion 2028-04-30 1 siteOther conditions: Obesity, Morbid, Postmenopause, Endometrial ThickeningView official trial listing → -
Completed NCT NCT07922512
Letrozole in Oligospermia With Eugonadotropic-Hypogonadism and Low Testosterone Estradiol Ratio
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2024-12-31 1 siteOther conditions: OligospermiaView official trial listing → -
Completed NCT NCT07932990
Halova Vaginal Ovules Versus Vaginal Estriol for Genitourinary Symptoms in Postmenopausal Women
Not yet reported Perfect Care Distribution 252 participants Est. completion 2026-06-22 1 siteOther conditions: Genitourinary Syndrome of Menopause (GSM), Vaginal Dryness, Vulvo Vaginal Atrophy (VVA)View official trial listing → -
Not yet recruiting NCT NCT07937605
KC1086 in Combination With Fulvestrant for HR-Positive, HER2-Negative Advanced Breast Cancer
Not yet reported Beijing Konruns Pharmaceutical Co., Ltd. 168 participants Est. completion 2030-11Other conditions: HR-positive, HER2-negative Locally Advanced or Metastatic Breast CancerView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Transdermal estrogen, Transdermal estradiol, Climara
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
